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10 Psychopathology in borderline intellectual functioning
 
The term Borderline Intellectual Functioning (BIF) refers to intellectual functioning 
between normal intellectual functioning and intellectual disability (ID) (see figure 1). 
ID is defined as a total intelligence quotient (TIQ) of  2 or more standard deviations 
below the mean on the normal curve of  intelligence and BIF as between 1 and 2 stan-
dard deviations (SD) below the mean. Roughly this category of  BIF corresponds with 
a TIQ on a standardised intelligence test between 70 and 85. According to the normal 
IQ distribution as much as 13.59% of  the population, i.e. in the Netherlands over 2 
million people, fall into this category.
Borderline intellectual functioning
Figure 1. Normal curve of the distribution of intelligence in the general population. The intelligen-
ce quotient (IQ) is a score derived from one of the standardized tests designed to assess human in-
telligence. The median raw score of the normative sample is defined as an IQ of 100. Each standard 
deviation (SD) up or down equals 15 IQ points. By this definition, approximately two-thirds of the 
population scores between IQ 85 and IQ 115. BIF is defined as an IQ between 1 and 2 SD below the 
mean (IQ 70-85) and ID is defined as an IQ of 2 SD of more below the mean (IQ< 70).
In most cases people with BIF live unnoticed in the community. They are not easily 
recognizable by specific features, personality traits or behavioural phenotypes. People 
with BIF often try very hard to be ‘normal’ and are mostly successful in masking their 
disabilities. On the one hand, this is an advantage as it helps them to maintain them-
selves in society. On the other hand, they have to always stretch their efforts to the 
maximum and consequently are more at risk of  developing psychiatric disorders than 
people with higher IQs. Besides, because they are so good in masking their relatively 
low IQ, they run the risk of  being approached as if  they have a higher IQ and get 
explanations about illness and treatment that are too complicated. 
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In fact, it has been shown that compared to people with higher IQs (TIQ> 85) and 
possibly also compared to those with lower IQs (TIQ< 70), children and adults with 
BIF are at increased risk for the development of  mental health problems.1–5 But, they 
seem to be less likely to receive treatment3 and if  they do get treated, they are more li-
kely to get psychotropic drugs than psychotherapy. 3 As a group they are understudied. 
More knowledge about psychopathology in this group is needed. 
It is the aim of  this thesis to study the nature and severity of  psychiatric symptoms 
and psychiatric disorders in people with BIF who became so seriously ill that they had 
to be referred to secondary care units in which BIF is a focus of  attention.
 
BIF as diagnostic category
Borderline Intellectual Functioning (BIF) has always been a diffi cult concept. It had 
different names, different boundaries, and travelled through the different versions of  
the Diagnostic and Statistical Manuals of  mental disorders (DSMs) starting as a solid 
element of  - what we now call – intellectual disability (ID) in the DSM I and ending, 
in DSM-5, as a V-code literally in last place.6
In the fi rst two editions of  the DSM, BIF was the lightest level of  mental defi ciency; 
what we now call ID.7,8 It was a disorder. Later, in the DSM III, the DSM III-R and 
the DSM-IV, mental retardation was placed as a disorder on axis II, along with the 
personality disorders9–11. Meanwhile, BIF was no longer the lightest level of  mental 
retardation. This place had been taken over by mild mental retardation (IQ 50-70). BIF 
had become a so-called V-code (on axis II). This implied that it was no longer consi-
dered to be a disorder per se. In the DSM-IV V-codes are defi ned as additional conditions 
that may be a focus of  clinical attention. The description of  BIF in the DSM-IV is shown in 
box 1. In the DSM-5, BIF is also a V-code. The defi nition of  V-codes in the DSM-5 is 
other conditions that may be a focus of  clinical attention and BIF is coded under other circum-
stances of  personal history. 
V62.89 Borderline Intellectual Functioning DSM-IV
This category can be used when the focus of clinical attention is associated with bor-
derline intellectual functioning, that is, an IQ in the 71-84 range. Diff erential diagnosis 
between Borderline Intellectual Functioning and Mental Retardation (an IQ of 70 or 
below) is especially diffi  cult when the coexistence of certain mental disorders (e.g. 
Schizophrenia) is involved. Coding note: This is coded on Axis II.
V62.89 Borderline Intellectual Functioning DSM-5
This category can be used when an individual’s borderline intellectual functioning is 
the focus of clinical attention or has an impact on the individual’s treatment or prog-
nosis. 
With the criteria for BIF from the DSM-III onwards it is still acknowledged that the 
presence of  this vulnerability may play a role in treatment and it still is possible to 
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mark it as a focus of  clinical attention. However, since BIF is no more listed in the le-
vels of  severity of  the disorder ID, the classification systems of  mental disorders seem 
to conspire with the people with BIF themselves to keep their psychological problems 
out of  sight. Therefore, it is not surprising that the association of  BIF with psychiatric 
disorders is rarely studied. 
Special outpatient clinics for BIF
In the Netherlands, in contrast to most other countries, people with BIF and co-mor-
bid psychiatric disorders are eligible for specialized psychiatric outpatient services for 
patients with ID. Unfortunately, there they are lumped with patients with a mild intel-
lectual disability (mild ID) in a single group called Licht Verstandelijk Gehandicapten 
(LVG) or – nowadays - Lichte Verstandelijke Beperking (LVB).12,13 However, as the 
IQs of  all patients in the specialised outpatient clinics of  Rivierduinen are assessed it 
is possible to study patients with BIF apart from those with mild ID. 
Rivierduinen, a large regional mental health care provider, has two centres for psychi-
atry and intellectual disability (CPID): Kristal, centre for psychiatry and intellectual 
disability, location Leiden and location Gouda. The two CPID offer multidisciplinary 
integrative diagnostics and treatment for psychiatric patients with an IQ< 85. At the 
two CPID next to IQ the developmental perspective is always taken into account, 
including social and emotional development and level of  adaptive functioning, in in-
terpreting psychiatric symptoms and classifying psychiatric disorders.14 During the 10 
years of  its existence Kristal has built up much clinical experience in the diagnostics 
and treatment of  psychiatric disorders of  patients with low IQs. Treatments have been 
developed and adapted to fit in with the cognitive and social-emotional abilities of  
patients with low IQs and are described in the care-program ‘Psychiatry and Intellec-
tual Disability’. 
Routine Outcome Monitoring
Routine Outcome Monitoring (ROM) was developed in 2002 by the Leiden University 
Medical Centre, the University of  Amsterdam and Rivierduinen.15,16 Within mental 
health care, ROM is used to measure treatment outcome, by routinely or periodically 
measuring the nature and severity of  psychiatric symptoms, at baseline and during tre-
atment. Goals of  ROM include 1. determining the nature and severity of  symptoms 
at baseline; the moment of  first presentation in the clinic 2. establishing the course of  
symptoms over time and 3. visualizing the effect of  treatment. Collected data can be 
used for scientific research. A very important part of  routine outcome monitoring is 
the fact that the system allows for feedback to treating psychiatrists, psychologist and 
other health care practitioners.
Patients are informed about possible use of  anonymised data from ROM for research 
purposes. If  people object to such use, their data is removed. A comprehensive pro-
tocol safeguards anonymity of  the patients and ensures proper handling of  the data. 
Chapter 1 General introduction 13
The Medical Ethical Committee of  the Leiden University Medical Centre (LUMC) 
approved the regulations and agreed with this policy.16
At Kristal, Centre for Psychiatry and Intellectual Disability, ROM was introduced 
starting at the end of  2009. The goals of  this ROM especially for patients with low 
IQs (TIQ< 85), were similar to the original goals. However, the use of  assessment 
instruments in daily clinical practise, especially self-report questionnaires, in psychi-
atric patients with low IQs was a novelty. This was at least partly due to the lack of  
adequately translated and tested psychiatric assessment instruments in the Dutch 
language.17 There were only a few measures available especially developed for people 
with intellectual disabilities and little was known about the utility of  existing ‘regular’ 
assessment measures. We did not find any literature on the use of  (self-report) assess-
ment instruments in psychiatric patients with BIF. 
Because, in addition to the goals of  ROM in general mental health care we wanted to 
be able to compare patient groups with lower IQs (TIQ< 85) with those of  average 
or above average intelligence we decided to use existing non-altered ROM measures 
where possible. One of  the first goals of  this thesis was to test the utility and psy-
chometric properties of  one of  the primary screeners and general psychopathology 
outcome measures of  ROM in regular mental health care, the Brief  Symptom Inven-
tory (BSI).18,19
Some alterations to the ROM process were made. Most importantly an ‘assisted com-
pletion format’ was used. In this format assessment was conducted in a one-to-one 
setting. Instruction and items of  the questionnaires were read in order, either together 
with the patient or verbatim to the patient. The answer feedback sheet contained both 
numerical and written representations. Language was adapted when needed, meaning 
that the same item was repeated in simplified wordings. Previous research showed that 
assisted completion influenced the patients’ ratings of  symptoms only modestly and 
did not affect the psychometric properties.20,21 
Aim of the studies and outline of the thesis
The overall aim of  the studies described in this thesis was to learn more about the 
nature and severity of  psychiatric symptoms and psychiatric disorders in secondary 
mental health care outpatients with BIF. In order to do so, we used anonymised 
diagnostic information recorded in the official registration system of  the electronic 
patient file, we investigated the utility and psychometric properties of  the BSI and we 
then used ROM data from both patients from regular mental health care (RMHC) and 
patients with BIF and/or mild ID to look at symptom profiles and prognostic factors 
of  treatment.
Chapter 2 describes in detail the history of  the concept of  BIF throughout previous 
DSMs and other classifications systems and its place in DSM-5. It provides infor-
mation about BIF and on the importance of  placing the concept of  BIF in the right 
context and in the right place in future DSMs. 
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In chapter 3 we address the question with which psychiatric disorders people with BIF 
present themselves in mental health care by reporting the rates of  DSM-IV-TR axis 
I diagnoses of  mental health care outpatients with BIF compared to patients from 
RMHC and patients with mild ID. 
In chapter 4 rates of  DSM-IV-TR axis II diagnoses were compared in the same way. 
In chapter 5 we describe the feasibility and psychometric properties of  the Brief  
Symptom Inventory (BSI) as a ROM assessment measure in patients with BIF and 
mild ID. 
Chapter 6 describes BSI symptom profiles of  outpatients with BIF and either major 
depressive disorder or posttraumatic stress disorder, compared to symptom profiles 
of  outpatients from regular mental health care and outpatients with mild ID. 
In chapter 7, to learn more about possible prognostic factors in the treatment of  psy-
chiatric disorders in BIF, the aim was to explore whether gender, age, level of  ID and 
cluster B personality disorders (PD) were associated with treatment outcome.
Last, in chapter 8 the main results are summarised, results and clinical implications are 
discussed and recommendations are provided for the improvement of  mental health 
care in patients with BIF and for future research. 
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Abstract
Borderline intellectual functioning (BIF) is an important and frequently unrecognized 
co-morbid condition relevant to the diagnosis and treatment of  any and all psychia-
tric disorders. In the Diagnostic and Statistical Manual of  mental disorders (DSM)–IV-TR, 
BIF is defined as having an Intelligence Quotient (IQ) in the 71-84 range. In DSM-5 
IQ boundaries are no longer part of  the classification, leaving the concept of  BIF 
without a clear definition. This modification of  the classification of  BIF is one of  the 
least highlighted changes in the DSM-5. In this paper we describe the history of  the 
classification of  BIF and provide information about BIF and on the importance of  
placing the concept of  BIF in the right context and in the right place in future DSMs 
and other classification systems like the International Classification of  Disease (ICD).
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Introduction
One of  the least highlighted changes in the DSM-5 is the modification of  the classi-
fication of  Borderline Intellectual Functioning (BIF).1 Contrary to earlier versions of  
DSM, Intelligence Quotient (IQ) boundaries are no longer part of  the classification, 
leaving the concept of  BIF without a clear definition. IQ scores are, over most of  
the range, well described by a normal distribution. The term BIF describes the group 
of  people that function on the border between normal intellectual functioning and 
intellectual disability (ID), between 1 and 2 standard deviations below the mean on 
the normal curve of  the distribution of  intelligence, roughly an IQ between 70 and 
85. According to the normal curve, as much as 13.6% of  the population falls into this 
category. BIF has always been a difficult concept. It had different names, different 
boundaries, and travelled through earlier DSMs starting as a solid element of  mental 
deficiency in the DSM I and ending, in DSM-5, as a V-code literally in last place. The 
classification of  BIF in DSM-5 has followed a similar path as in the international 
classification of  disease (ICD).2,3,4 And although ICD-11 is not due until 2017, ICD-11 
and DSM-5 will likely share the same view. 
In DSM-5, similar to the new classification of  ID, IQ test scores are removed from 
the diagnostic description of  BIF. This is detrimental to the concept of  BIF, since it 
was the only criterion left. Within the classification of  ID, even in DSM-5, the im-
portance of  standardized IQ scores is well described. As a V-code BIF ultimately has 
been defined solely by IQ. By removing the IQ criterion, DSM-5 no longer provides 
any criteria for what exactly is BIF. ICD-11 will probably do the same or might score 
out the classification of  BIF altogether. This, in spite of  the fact that it is critically an 
important and frequently unrecognized co-morbid condition vastly relevant to the 
diagnosis and treatment of  any and all psychiatric disorders. 
In this paper we describe the history of  the classification of  BIF and provide infor-
mation about BIF and on the importance of  placing the concept of  BIF in the right 
context and in the right place in future DSMs and other classification systems like the 
ICD.
History of borderline Intellectual functioning
Before DSM-I, there were different cut offs in IQ-scores used when it comes to - 
what is now called - Intellectual disability (ID) or intellectual developmental disorder 
(IDD). Consequently, ID included what we now call BIF as part of  ID. In DSM-I, 
BIF was called mild mental deficiency, listed in the section Mental Deficiency.5 The 
classification applied when there was both an IQ of  about 1 to 2 standard deviations 
below the mean – equalling an IQ between 70 and 85 - and functional impairment. 
DSM-I already made a plea for a classification based on more than a standardized 
IQ test alone. It states that cultural, physical and emotional determinants, as well as 
school, vocational and social effectiveness should be taken into consideration.5 
In DSM-II, BIF was called borderline mental retardation. It had a place in the section 
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Mental Retardation.6 The boundaries of  borderline mental retardation (IQ 68-83) differed 
slightly from those of  mild mental deficiency in the DSM-I, but the other criteria 
remained the same. The place of  BIF dramatically changes in DSM-III.7 In DSM-III, 
BIF is no longer part of  what by then are called intellectual disorders. Mental retardation 
is now covered in the chapter of  disorders usually first evident in infancy, childhood 
or adolescence. BIF is now a V-code ‘exiled’ to the chapter “V-codes for conditions 
not attributable to a mental disorder that are the focus of  attention or treatment” in 
the far back of  the DSM. The V-code BIF is to be used when the focus of  attention 
or treatment is associated with BIF, i.e. an IQ in the 71-84 range. Where in the classi-
fication of  mental retardation it is still recognized and described that IQ should not 
be the only criterion in making a diagnoses of  mental retardation or in evaluating it’s 
severity, in the V-code BIF, IQ is now the only criterion left.
ICD 
In the ICD, borderline intellectual functioning has a similar history being excluded 
from the section of  mental retardation at about the same time.2,3 This change obvious-
ly caused a significant decrease in the prevalence of  ID. In the DSM-III the argument 
was that the large majority of  individuals with borderline intellectual functioning 
does not have significantly impaired adaptive behavior.7 For more than 30 years then, 
classification of  BIF does not change. DSM-III, IV and IV-TR all use the V-code BIF. 
During the same time in the ICD, BIF got shifted to the residual code R41.8; a rather 
non-specific code referring to “other and unspecified symptoms and signs involving 
cognitive functions and awareness”.4 
Now, DSM-5 has further stripped the definition of  BIF. The V-code BIF in DSM-5 
is listed in Other Conditions That May Be a Focus of  clinical Attention, under Other Circum-
stances of  Personal History. It ceases to provide any description of  what BIF entails. The 
DSM-5 just states that the V-code can be used when an individual’s borderline intellec-
tual functioning is the focus of  clinical attention or has an impact on the individual’s 
treatment or prognosis.
Vulnerability and mental health
According to DSM and ICD, BIF is not a disorder. But people with BIF, or an IQ 
between 70 and 85, do comprise a vulnerable group. Genetic liability, biological causes 
like perinatal difficulties and epigenetic factors such as socioeconomic status and ma-
ternal stress all contribute to BIF.8 Children with BIF are uniquely at risk for receiving 
poor parenting.9 Mothers of  children with BIF were less positive and sensitive; sho-
wed less positive engagement even though their children did not exhibit more difficult 
child behaviour. Given the importance of  positive and sensitive parenting for secure 
attachment and adaptive regulatory capabilities, children with BIF might be at risk at a 
very early age.9 In adult life, contrary to the DSM-III statement, perhaps increasingly 
so due to the growing complexity of  society, many people with BIF do have pro-
Chapter 2 Where goes borderline intellectual functioning 21
blems in adaptive functioning. In fact, they face difficulties across all areas of  ordinary 
life.10-14 They are at increased risk of  experiencing physical problems,13 poverty,15 have 
more difficulties with activities of  daily living,11 have limited social support11, 12 and no 
access to specialised services.15 They often live problematic lives, functioning under 
high strain but unnoticed by the rest of  society.15 Many people with BIF do not have 
psychiatric disorders, but people with BIF are more vulnerable for the development 
of  mental health problems than people of  average or above average intelligence and 
maybe also more vulnerable than people with mild ID.11, 15-20 Several studies show 
increased risk for the development of  almost all psychiatric disorders in childhood as 
well as in adulthood, including substance misuse and personality disorders.11, 12, 16, 17, 21, 22
When people with BIF do develop psychiatric disorders, especially when there are 
additional problems in adaptive functioning, BIF and it’s impact on the presentation, 
diagnostics and treatment of  these psychiatric disorders should not be overlooked. 
Because even though BIF is not a disorder and not a disability by itself, when peop-
le with BIF develop a psychiatric disorder, BIF is an impediment in diagnostics and 
treatment. 
Unfortunately, despite the fact that BIF is a vulnerability and has impact on co-morbid 
disorders, people with BIF are almost invisible in research and – when they develop 
co-morbid psychiatric disorders – are rarely identified as having BIF in mental health 
care. The DSM-5 classification of  BIF as is, is not likely going to improve on this 
problem.
Why paying serious attention to BIF remains important
As is the case with many psychiatric diagnoses, the classification BIF can have a 
stigmatizing effect. People with a low IQ often themselves try to prevent their limited 
intellectual capabilities being exposed by painstakingly trying to behave ‘normally’ and 
masking their disabilities and special needs. Also, society as a whole, tries to look away 
from BIF. For example, people with BIF are not entitled to the special support servi-
ces for intellectually disabled people because their IQs are deemed too high. Unlike 
other countries, in the Netherlands, individuals with BIF and co-morbid psychiatric 
disorders are eligible to the same specialised mental health care services as people 
with ID. In this way special attention to the impact of  BIF on co-morbid psychiatric 
disorders and the special skills training mental health workers need to treat this patient 
group is adequately guaranteed. It is doubtful whether general mental health care 
services are able to deliver the same adequate care. It is important to take BIF into 
account as a complicating factor from the start of  diagnostics and treatment and to 
train mental health workers in this respect. 
At this time however, most mental health care professionals are not trained in recogni-
zing BIF and miss the extra skills needed for effectively treating psychiatric disorders 
in patients with BIF. Right now psychiatric patients with BIF in regular mental health 
care are more likely to get psychotropic drugs (and more likely antipsychotics and se-
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datives than antidepressants) than psychotherapy.11,23 Psychiatric treatments in regular 
mental health care are not adapted to the cognitive limitations of  such patients, like 
deficits in memory function17 of  patients with BIF. Results from daily clinical practise 
show that many forms of  treatment can be adapted to the cognitive abilities of  people 
with BIF but also that neglect of  BIF in psychiatric patients leads to longer duration 
of  treatment, more need for crisis intervention11,18 and limited or adverse treatment 
effect.
Conclusion
We recommend a renewed regard to the concept of  BIF and it’s place in DSM and 
other classification systems like ICD. A well-defined classification can improve visibili-
ty of  patients with BIF in mental health care, bridging the gap between high prevalen-
ce and low recognition and acknowledgement. Recognition of  patients with BIF and 
attention to specific mental health care needs is likely to improve the quality mental 
health care substantially for a group of  people that comes last too often. Even in the 
DSM-5 V-codes.
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Abstract
Objective In the Netherlands patients with borderline intellectual functioning (BIF) 
are eligible for specialized mental health care. This offers the unique possibility to exa-
mine the mix of  psychiatric disorders in patients who, in other countries, are treated in 
regular outpatient mental health care clinics. Our study sought to examine the rates of  
all main Diagnostic and Statistical Manual of  Mental Disorders, Fourth Edition, Text 
Revision, axis I psychiatric diagnoses in outpatients with BIF of  two specialized regi-
onal psychiatric outpatient departments and to compare these with rates of  the same 
disorders in outpatients from regular mental health care (RMHC) and outpatients with 
mild intellectual disabilities (ID).
Method Our study was a cross-sectional anonymized medical chart review. All partici-
pants were patients from the Dutch regional mental health care provider Rivierduinen. 
Diagnoses of  patients with BIF (BIF group; n= 235) were compared to diagnoses of  
patients from RMHC (RMHC group; n=1026) and mild ID patients (mild ID group; 
n= 152). 
Results Compared with the RMHC group, psychotic and MDD were less common in 
the BIF group, while posttraumatic stress disorders and V-codes were more common. 
Compared with the mild ID group psychotic disorders were significantly less com-
mon. 
Conclusion Mental health problems in people with BIF may be not well addressed in 
general psychiatry, or by standard psychiatry for patients with ID. Specific attention to 
this group in clinical practice and research may be warranted lest they fall between two 
stools.
Chapter 3 Psychiatric disorders in outpatients with borderline intellectual functioning 27
Introduction
In the International Classification of  Diseases, 10th Revision, there is no specific code 
for it, but in the DSM-IV-TR, as well as in DSM-5, borderline intellectual functioning 
(BIF) is a V-code that can be used to signify problems associated with subaverage 
intellectual performance.1–3 These patients function in between people with average or 
above average intelligence and people with ID. Adults with BIF are believed to suffer 
from high rates of  psychiatric disorders and rely mostly on outpatient treatment.4 In 
most countries they are not considered part of  the ID population and are treated in 
the same clinics as patients without ID. However, it is unknown to what extent the 
mix of  disorders with which they present themselves in mental health outpatient 
clinics differs from patients without ID. It is also unknown to what extent this mix of  
disorders differs from patients with lower intelligence quotients (IQs). Most studies 
in the general population, as well as in outpatients, did not include people with BIF.5–7 
This may be important, as the prevalence of  mental health disorders has been repor-
ted to vary by the severity of  the ID.8
Unlike most other countries, in the Netherlands, patients with BIF and comorbid 
psychiatric disorders are eligible for the same specialist psychiatric services as patients 
with ID. For instance, the Dutch regional mental health care provider Rivierduinen has 
over 10 years of  experience with two outpatient mental health care centres specialized 
in psychiatry and ID, mainly for patients with BIF and mild ID, apart from outpatient 
clinics for people without ID. Well established referral pathways and focus on pa-
tients with BIF as a separate group made referral of  patients with BIF and psychiatric 
disorders to specialized mental health care the default procedure. Using data from 
these two specialized outpatient clinics and from a general outpatient clinic of  Rivier-
duinen operating in the same region, we were able to compare psychiatric morbidity 




Our study was a cross-sectional anonymized medical chart review. All participants 
were patients from the Dutch regional mental health care provider Rivierduinen.
We compared anonymized data of  patients from two regional secondary care adult 
outpatient departments, specialized in psychiatry and ID (CPID; centres for Psychi-
atry and Intellectual Disability; BIF and mild ID groups) with anonymized data of  
patients from a regular secondary care outpatient department (Regular Mental Health 
Care (RMHC) group). The BIF and mild ID groups came from the complete catch-
ment area of  Rivierduinen and the RMHC group came from one particular region 
within this area (Katwijk, Zuid Holland, the Netherlands). Both groups consisted of  
outpatients registered on January 1, 2011. All diagnoses were the DSM-IV-TR2 axis I 
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diagnoses as recorded in the official registration system of  the electronic patient file. 
In the BIF and mild ID groups diagnoses were based on the integrative approach of  
Došen.9–11 For people with ID, the integrative diagnosis considers the developmental 
perspective as the fourth dimension in addition to the biopsychosocial model. In daily 
clinical practice this means that in order to consider all four dimensions, patients are 
always assessed multidisciplinary, by at least a certified and experienced psychiatrist, 
a certified and experienced mental health psychologist and an experienced psychia-
tric community worker. DSM-IV-TR diagnoses are formulated using the Diagnostic 
Manual-Intellectual Disability (DM-ID) criteria.12 The DM-ID offers adaptations of  
DSM-IV-TR diagnostic criteria and provide guidelines for making accurate psychiatric 
diagnoses in patients with various levels of  ID. In the RMHC group diagnoses were 
formulated using the DSM-IV -TR.2 
Among the 599 registered at the two specialized centres, diagnostic information was 
available for 576 patients (95.8%). Of  these 576 patients, 511 (85.3%) were diagnosed 
with either BIF or mild ID. A total of  65 patients (11.3%) were excluded from the 
present study because level of  ID was not known at the time (2.3%) or because they 
had moderate (8.9%) or severe (0.2%) ID. For the RMHC group diagnostic infor-
mation was available for 1054 of  the 1254 registered patients (84.1%). Among these 
patients, 14 (1.1%) were diagnosed with BIF. These patients were excluded from the 
current analyses. 
Within our organization, patients with average or above average intellectual functio-
ning with pervasive developmental disorders (PDDs) are referred to a special centre 
for autism spectrum disorders, while patients with a PDD and ID are referred to one 
of  the two CPID. This would lead to a possible referral bias when comparing the rates 
of  autism because patients with PDDs were underrepresented in the RMHC group 
compared to the BIF and mild ID groups. Therefore, patients with PDDs were exclu-
ded from the current analyses. One hundred-and-twenty-four (24.3%) individuals were 
excluded from the BIF and mild ID groups and another 14 (1.1%) individuals were 
excluded from the RMHC group because of  a diagnosis of  PDD. 
A total of  235 individuals were diagnosed with BIF and 152 individuals had a mild 
ID. Thus, the final groups consisted of  235 participants with BIF (BIF group), 1026 
participants from regular mental health care (RMHC group) and 152 participants with 
mild ID (mild ID group).
Measures
Demographic variables and diagnostic categories
The following variables were collected for each patient from the electronic patient 
file: age, sex, level of  ID and DSM-IV-TR axis I diagnoses. All DSM-IV-TR axis I 
diagnoses recorded in the official registration system of  the electronic patient file were 
registered. For analyses, the DSM-IV-TR diagnoses were categorized as follows: psy-
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chotic disorders (subdivided into schizophrenia and psychotic disorder Not Otherwise 
Specified (NOS)), mood disorders (subdivided into major depressive disorder (MDD), 
dysthymic disorder, depressive disorder NOS and bipolar disorder), anxiety disor-
ders (subdivided into posttraumatic stress disorder (PTSD), panic disorder, genera-
lized anxiety disorder, social and specific phobia and obsessive compulsive disorders 
(OCD)), somatoform disorders (subdivided into somatisation disorder, undifferenti-
ated somatoform disorder, conversion disorder, pain disorder and hypochondria) and 
V-codes. Individuals with attention deficit hyperactivity disorder (ADHD) and impulse 
control disorders NOS were categorized together as ADHD and impulse control 
disorders. Alcohol abuse and alcohol dependence were categorized together as alcohol 
abuse and dependence. Cannabis abuse and cannabis dependence were categorized to-
gether as cannabis abuse and dependence. The remaining diagnoses were not analysed 
because rates were too low or they were absent. These included cognitive disorders, tic 
disorders, sexual disorders, other substance abuse disorders, eating disorders and sleep 
disorders. 
Intelligence
In the BIF and mild ID groups, level of  ID was based on IQ testing, using the 
Wechsler Adult Intelligence Scale (WAIS-III).13–15 Following DSM-IV-TR criteria, par-
ticipants were divided into two groups: BIF (Total Intelligence Quotient (TIQ) 70-85) 
and mild ID (TIQ 50-70). There was no IQ testing in the RMHC group.
Statistical analyses
Demographic and clinical variables were compared among the BIF group and the 
RMHC and mild ID groups using analysis of  variance (ANOVA) with host-hoc Bon-
ferroni correction for continuous variables (for example, age) and Chi-square tests for 
dichotomous and categorical variables (for example, gender and diagnoses). First, all 
three groups were compared using a Chi-square test. Second, when overall differences 
were found, a comparison was conducted comparing the BIF group with both the 
RMHC and mild ID groups. In additional analyses outcomes were corrected for gen-
der and age using binary logistic regression. All analyses were performed using SPSS 
Statistics version 16.0 (SPSS Inc, Chicago, IL). for Windows. When chi-square condi-
tions were not met, percentages were given but no statistical analyses were performed. 
A conservative level of  significance was set at p≤ 0.01.
Results
Demographic characteristics 
As shown in Table 1, The RMHC group consisted of  1026 participants. A total of  
235 individuals were diagnosed with BIF and 152 individuals had a mild ID. Even 
though the percentage of  females was highest in the BIF group (66.8%), there was no 
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significant difference among the three groups (χ²= 5.65, df= 2, p= 0.06). There was a 
significant difference in mean age among the three groups (p< 0.001). The mean age 
was lowest in the BIF group (33.4, SD= 12.5) and highest in the RMHC group (44.3, 
SD= 16.6, p< 0.001). There was a significant difference in mean age between the BIF 
and the RMHC group (p< 0.001), as shown in table 2. There was no difference in 
mean age between the BIF and the mild ID group.
Comparison of diagnoses
The mean number of  DSM-IV-TR axis I diagnoses did not differ significantly among 
the three groups. Comparisons of  the percentages of  diagnostic categories among the 
three groups are presented in table 1. In table 2, percentages of  different disorder-ty-
pes are presented between the BIF group and the RMHC group on the one hand and 
the mild ID group on the other hand. 
Psychotic disorders 
A significant difference was found in the presence of  psychotic disorders among the 
three groups (χ²= 10.7, df= 2, p= 0.005), with the lowest rates (6.8%) in the BIF 
group (table 1). The rate of  schizophrenia was highest in the RMHC group (8.3%) 
and lowest in the BIF group (1.2%)(χ²= 15.5, p< 0.001). The rate of  psychotic disor-
ders NOS was highest in the mild ID group (8.6%) and lowest in the RMHC group 
(2.9%)(χ²= 11.8, df= 2, p< 0.003). Table 2 shows that the rate of  psychotic disorders 
was significantly lower in the BIF group compared to both the RMHC (14.7%) and 
the mild ID (15.1%) groups (χ²= 7.1, df= 1, p= 0.008). 
Mood disorders
There was a significant difference among the three groups in the overall presence of  
mood disorders (χ²= 40.6, df= 2, p< 0.001)(table1). This was also true for depressi-
ve disorder (χ²= 23.7, df= 2, p< 0.001). The highest rates of  overall mood disorders 
(36.2%) and MDD (21.2%) were in the RMHC group. The rate of  bipolar disorder 
was also highest in the RMHC group (6.7%). The overall presence of  mood disorders 
and the rate of  depressive disorder did not differ between the BIF (17.4%) and mild 
ID (20.4%) groups (table 2). Most groups of  mood disorders however, were too small 
to conduct statistical tests. 
Anxiety disorders (including PTSD) 
The rate of  all anxiety disorders taken together differed significantly among the three 
groups (χ²= 14.3, df= 2, p= 0.001)(table 1). This difference was mainly due to the 
higher rate of  PTSD in the BIF (19.6%) and mild ID groups (19.7%) compared to 
the RMHC (10.4%) group (χ²= 21.1, df= 2, p< 0.001). The rates of  panic disorder, 
generalized anxiety disorder, social phobia, specific phobia, OCD and anxiety disorder 
NOS did not differ much among the groups. Most groups of  specific anxiety disor-
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ders were too small to conduct statistical tests. There was no significant difference in 
the overall rate of  anxiety disorders, or in the rate of  PTSD between the BIF and the 
mild ID groups (table 2). 
Somatoform disorders
There was no significant difference among the three groups in the overall presence 
of  somatoform disorders (table 1). The different categories of  somatoform disorders 
were too small to conduct statistical tests.
Table 1. Demographic characteristics and statistical comparisons of the percentages of DSM-IV-TR 









Gender, n females (%) 603 (58.8%) 157 (66.8%) 96 (63.2%) 0.06
Age, mean (SD) 44.3 (16.6) 33.4 (12.5) 37.2 (13.6) < 0.001
Age, range 15.8 - 95.4 16.3-78.2 16.8-70.6
DSM-IV-TR axis I diagnoses, mean 
(SD)
1.46 (0.7) 1.49 (0.7) 1.38 (0.6) 0.30
DSM-IV-TR axis I diagnoses
Psychotic disorders 151 (14.7%) 16 (6.8%) 23 (15.1%) 0.005
    Schizophrenia 85 (8.3%) 3 (1.2%) 8 (5.3%) < 0.001
    Psychotic disorder NOS 30 (2.9%) 10 (4.3%) 13 (8.6%) 0.003
Mood disorders 371 (36.2%) 41 (17.4%) 31 (20.4%) < 0.001
    Depressive disorder 217 (21.2%) 21 (8.9%) 18 (11.8%) < 0.001
    Dysthymic disorder 37 (3.6%) 6 (2.6%) 4 (2.6%) –
    Bipolar disorder 69 (6.7%) 4 (1.6%) 5 (3.3%) –
    Mood disorder NOS 6 (0.6%) 7 (3.0%) 4 (2.6%) –
Anxiety disorders 237 (23.1%) 81 (34.5%) 45 (29.6%) 0.001
    PTSD 107 (10.4%) 46 (19.6%) 30 (19.7%) < 0.001
    Panic disorder 57 (5.6%) 10 (4.3%) 4 (2.6%) 0.26
    Generalized anxiety disorder 14 (1.4%) 3 (1.3%) 1 (0.7%) –
    Social phobia 16 (1.6%) 5 (2.1%) 2 (1.3%) –
    Specific phobia 6 (0.6%) 5 (2.1%) 1 (0.7%) –
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    Obsessive compulsive disorder 17 (1.7%) 7 (3.0%) 3 (2.0%) –
    Anxiety disorder NOS   58 (5.7%) 13 (5.5%) 6 (3.9%) 0.69
Somatoform disorder 26 (2.5%) 3 (1.3%) 5 (3.3%) 0.39
   Somatisation disorder 2 (0.2%) 0 (0%) 0 (0%) –
   Undifferentiated Somatoform    
   disorder
10 (1.0%) 2 (0.9%) 2 (1.3%) –
   Conversion disorder 4 (0.4%) 0 (0%) 3 (2.0%) –
   Pain disorder 4 (0.4%) 1 (0.4%) 0 (0%) –
   Hypochondria 8 (0.7%) 0 (0%) 0 (0%) –
ADHD or Impulse control disorder 135 (13.2%) 31 (13.2%) 10 (6.6%) 0.67
Alcohol abuses or dependence 68 (6.6%) 11 (4.7%) 5 (3.3%) 0.18
Cannabis abuse or dependence 22 (2.1%) 12 (5.1%) 2 (1.3%) 0.02
V-codes 97 (9.5%) 53 (22.6%) 20 (13.2%) < 0.001
All p-values based on Chi-square testing with 2 df, - conditions for chi-square test are not met. SD= Standard Deviation, BIF= 
Borderline Intellectual Functioning, ID= Intellectual Disability, RMHC= Regular Mental Health Care, NOS= Not Otherwise Speci-
fied, PTSD= Posttraumatic Stress Disorder, ADHD= Attention Deficit Hyperactive Disorder
Substance abuse/dependence
There was no difference in the presence of  alcohol and or cannabis abuse/dependen-
ce among the three groups (table 1). 
ADHD/ Impulse-control disorders
There was no significant difference in the percentage of  diagnosed ADHD/impul-
se-control disorders among the three groups (table 1). 
V-codes 
There was a significant difference in the percentage of  diagnosed V-codes among the 
three groups (χ²= 31.2, df= 2, p< 0.001)(table 1). The percentage of  V-codes was over 
twice as high in the BIF group (22.5%) compared to the RMHC group (9.5%)(χ²= 
31.2, df= 2, p< 0.001)(table 2). 
Continuation of table 1.
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Gender, n females (%) 157 
(66.8%)
603 (58.8%) 0.02 96 (63.2%) 0.46
Age, mean (SD) 33.4 (12.5) 44.3 (16.6) <0.001 37.2 (13.6) 0.06
DSM-IV-TR axis I diagnoses
Psychotic disorders 16 (6.8%) 151 (14.7%) 0.001 23 (15.1%) 0.008
    Schizophrenia 3 (1.2%) 85 (8.3%) – 8 (5.3%) –
    Psychotic disorder NOS 10 (4.3%) 30 (2.9%) 0.29 13 (8.6%) 0.08
Mood disorders 41 (17.4%) 371 (36.2%) <0.001 31 (20.4%) 0.47
    Depressive disorder 21 (8.9%) 217 (21.2%) <0.001 18 (11.8%) 0.35
Anxiety disorders 81 (34.5%) 237 (23.1%) <0.001 45 (29.6%) 0.32
    PTSD 46 (19.6%) 107 (10.4%) <0.001 30 (19.7%) 0.97
V-codes 54 (22.6%) 97 (9.5%) <0.001 20 (13.2%) 0.02
All p-values based on Chi-square testing with 1 df, ● p-value of statistical comparisons between the borderline ID and the 
RMHC groups, ** p-value of statistical comparisons between the borderline ID and the mild ID groups. SD= standard deviation, 
-= Conditions for chi-square test are not met, BIF= Borderline Intellectual Functioning, ID= Intellectual Disability, RMHC= Regu-
lar Mental Health Care, NOS= Not Otherwise Specified, PTSD= Posttraumatic Stress Disorder
Table 2. Demographic characteristics and statistical comparisons of the percentages of DSM-IV-TR 
axis I diagnoses between the BIF group and the RMHC and mild ID group.
Discussion
In the Netherlands, patients with BIF are eligible to specialized outpatient mental 
health care, offering the opportunity to examine psychiatric co-morbidity in a group 
of  people intellectually functioning in between people with and without an ID and 
often going unnoticed in most countries. In the current study, the rates of  DSM-IV-
TR axis I psychiatric disorders were compared among patients with BIF (BIF group), 
outpatients from regular mental health care (RMHC group) and outpatients with 
mild ID (mild ID group). To our knowledge there are no previous studies specifically 
focused on the rate of  psychiatric disorders of  patients with BIF in outpatient mental 
health care. Most striking differences, compared to the RMHC group, were the high 
rate of  PTSD and V-codes in the BIF group and the low rates of  psychotic disorders 
and MDD. Also compared to the mild ID group, psychotic disorders were significant-
ly less common in the BIF group. 
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The rate of  psychotic disorders was lower in the BIF group than in both the RMHC 
and the mild ID groups. Considering the association found in earlier studies between 
lower IQ scores and an increased risk for schizophrenia16–18 this is a notable finding. 
It is unlikely that BIF is associated with less chance of  becoming psychotic. Based 
on our experience we can say that psychotic patients with BIF are frequently referred 
from our outpatient department to teams specialized in the treatment of  psycho-
ses, like early detection and Intervention teams and functional assertive community 
treatment,19 more so than psychotic patients with mild ID who do not seem able to 
profit from the above-mentioned approaches. More research is needed to explore this 
further.
The low rates of  mood disorders in patients with BIF compared to the RMCH group 
is also notable. It is contrary to what may be expected from literature. Hurley et al.5 
found high rates of  mood disorders. We do not think it to be very probable that a 
BIF predisposes to less mood disorders than a more severe ID. This is in line with the 
absence of  differences in our sample between BIF and mild disorders in this respect. 
We do not think that our therapists missed these diagnoses either. However, depressed 
patients may have been referred less often to our department as a lower mood is less 
easily recognized and labelled as a possible disorder by significant others.20,21 
Compared to the RMHC group PTSD was almost twice as common in the BIF group 
and rates did not differ between patients with BIF and patients with mild ID. We 
know that patients with ID are more likely to experience traumatic events.22–24 They 
are also more vulnerable to the disruptive effects of  trauma, and thus to PTSD.12 
Thus far PTSD in patients with BIF is underexposed in the literature. Our data war-
rant more attention to this subject. 
Another result that merits discussion was the high rate of  V-codes in the BIF group 
compared to both the RMHC and the mild ID groups. In the DSM-IV-TR, V-codes 
are used to indicate “other conditions that may be a focus of  clinical attention”. V-co-
des include, for instance, codes for relational problems, occupational problems and 
phase of  life problems. In general, V-codes are used to capture clinically significant 
distress or problems functioning in daily life.2 At the least, the high rates of  V-codes in 
the BIF group suggest that these patients present with complex problems: ID, psychi-
atric disorders and clinically significant distress or problems functioning in daily life as 
signified by these V-codes. The alternative explanation might be that this specialized 
clinic is more likely to record these additional diagnoses. More research is needed to 
explore this further.
The present study has several strengths. First, this study examines a large sample BIF 
outpatients which is a population not considered part of  the ID population in most 
countries. They are thought to be especially vulnerable for developing psychiatric 
disorders and less likely to receive adequate treatment.4 Second, in the BIF and mild 
ID-patients the level of  ID was always recently established and based on the stan-
dardized WAIS-III, which ensured that the labels of  BIF and mild ID were carefully 
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applied. Third, a broad range of  DMS-IV-TR diagnoses was included. Fourth, these 
diagnoses were the diagnoses as recorded in the official registration system of  the 
electronic patient file, applied after a careful diagnostic process. Fifth, the fact that the 
findings are based on large samples from a naturalistic outpatient setting makes them 
generalizable to the clinical field of  interest. 
The results should also be interpreted in the light of  some limitations. First, issues of  
referral most likely introduced some bias. The BIF group consisted of  significantly 
more females than the RMHC group. In addition, the mean age in the BIF and mild 
ID groups was lower than in the RMHC group. Using binary logistic regression to 
correct for gender and age did not alter the outcomes (data not shown). Post hoc 
analyses showed that the difference in gender was accounted for by the high rate of  
female PTSD patients with BIF or mild ID. When PTSD patients were excluded, there 
was no longer a difference in male-to-female ratio (data not shown). The mean age 
was lowest in the patients with BIF. This could mean that individuals with BIF deve-
lop psychiatric symptoms at a younger age. It could also mean that older individuals 
with BIF are less likely to be referred to specialized services. In both the BIF and mild 
ID groups there were many patients diagnosed with an autism spectrum disorder be-
cause of  a special referral policy. They were excluded from analysis, which means that 
part of  the initial sample was not included. However, most patients diagnosed with 
an autism spectrum disorder did not report other psychiatric disorders and only made 
up a minor part of  the rates of  psychiatric disorders in the ID groups, so the extent 
of  the introduced bias probably is small. A second limitation is that results apply only 
to outpatients and cannot be generalized to more severely ill in-patients. Third, There 
was no IQ testing in the RMHC group. Fourth, demographic information was limited 
and information on treatment was not available. And fifth, co morbidity of  axis II 
disorders was not accounted for. Future research could investigate the rates and co 
morbidity of  axis I and II disorders in patients with a BIF.
Conclusion
In conclusion, results indicate that individuals with BIF are most commonly diagnosed 
with PTSD and V-codes. Compared to patients from regular mental health care they 
are younger, less likely to be diagnosed with psychotic and mood disorders and more 
likely with anxiety disorders, more specifically PTSD. Compared to their peers with 
mild ID referred to the same service, they are less likely to be diagnosed with psycho-
tic disorders. Perhaps, the results remind us that this in many countries invisible group 
in the middle may not be well addressed by general psychiatry, or by ID psychiatry. 
Specific attention may be warranted in clinical practice as well as in research lest they 
fall between two stools.
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Abstract
Background There is little research on the subject of  personality disorder (PD) in 
individuals with borderline intellectual functioning (BIF). Unlike in most countries, 
in the Netherlands, patients with BIF are eligible for specialized mental health care. 
This offers the unique possibility to examine the rates of  PD in patients, who in other 
countries are treated relatively invisible in regular mental health care.  
Aim To compare, in a naturalistic setting, the frequency PD diagnoses in outpatients 
with BIF to outpatients from regular mental health care and outpatients with mild ID.
Methods We compared the rates of  all DSM-IV-TR axis II PD in outpatients with 
BIF (BIF group; n= 235) with rates of  the same disorders in outpatients from regular 
mental health care (RMHC group; n= 1026) and outpatients with mild intellectual 
disability (ID) (mild ID group; n= 152) in a naturalistic cross-sectional anonymized 
medical chart review.  
Results Over half  of  the patients with BIF (52.8%) were diagnosed with a PD, 
compared to one in five in the RMHC group (19.3%) and one in three of  de mild ID 
group (33.6%). All PD diagnoses, except for cluster A PD and histrionic PD, were 
most frequently diagnosed in the BIF group. The majority of  PD patients had one of  
more comorbid axis I disorder.
Conclusion There is a high frequency of  PD diagnoses in BIF outpatients in daily 
clinical practise. In anticipation of  further scientific research, results suggest that PD 
should not be overlooked in patients with BIF. 
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Background 
Borderline intellectual functioning (BIF) is a complex clinical entity, which has barely 
been studied.1 It is defined as a total intellectual quotient (TIQ) between 1 and 2 stan-
dard deviations below average (TIQ 70-85), but has no clear diagnostic code in either 
DSM-IV-TR, DSM-5 or ICD-10.1–5 According to the normal IQ distribution 13.6% 
of  the population has an IQ between 70 and 85; according to available studies the 
percentage lies between 12 and 18%.6,7 In most countries people with BIF live unnoti-
ced in the community. Because they are not considered part of  the intellectual disabi-
lity (ID) population (TIQ< 70), they are not eligible for specialist ID services. If  they 
develop psychiatric disorders, they depend largely on regular mental health care, where 
they represent a relatively invisible patient group. In the Netherlands patients with BIF 
are focused on as a separate group and they are eligible to the same specialised mental 
health care services as patients with ID. Because of  well-established referral pathways, 
referral of  patients with BIF and psychiatric disorders to specialized mental health 
care has become the default procedure. This offers the unique opportunity to exami-
ne, in a naturalistic setting, the psychiatric co-morbidity of  this otherwise largely hid-
den population. We previously showed that the rates of  axis I psychiatric disorders of  
patients with BIF differ from both patients from regular mental health care (RMHC) 
and patients with mild intellectual disabilities (ID).2 In this paper we discuss whether 
this also hold true for axis II personality disorders (PD).
Hassiotis et al.8 -using data from a UK-wide cross-sectional survey of  8450 people - 
showed 37.4% of  people screened as having borderline intelligence, were diagnosed as 
having a PD using the structured clinical interview for DSM-IV axis II PD (SCID-II). 
In comparison, in the normal intellectual functioning group this was 27% . We are not 
aware of  published studies on PD specifically focusing on patients with BIF in mental 
health care, nor do we know of  any studies comparing rates of  PD among patients 
with either normal intelligence, BIF or mild ID.
Aim
The Dutch regional mental health care provider Rivierduinen has over 10 years expe-
rience with 2 outpatient mental health care centres specialized in psychiatry and ID 
(CPID; Centres for Psychiatry and Intellectual Disability), mainly for patients with 
BIF and mild ID, apart from outpatient clinics for people without ID. Using data from 
these two CPID and from a general outpatient clinic of  Rivierduinen operating in the 
same region, the aim of  the present study was to compare, in a naturalistic setting, the 
frequency of  PD diagnoses in patients with BIF to outpatients from regular mental 
health care and outpatients with mild ID. In this study we focus on official DSM-IV-
TR diagnoses because treatment plans and therefore extent, nature and content of  
treatment are based on these diagnoses.
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Materials and methods
Participants
Our study was a naturalistic anonymized cross-sectional medical chart review. All 
diagnoses were the official DSM-IV-TR axis II diagnoses as registered in the electronic 
patient file. Treatment plans are based on these diagnoses and therefore are highly re-
levant. All participants were patients from the Dutch regional mental health care pro-
vider Rivierduinen. We compared data of  patients from two CPID, regional secondary 
care adult outpatient departments (Kristal Centre for Psychiatry and ID in the Leiden 
and Gouda locations; BIF and mild ID groups) with anonymized data of  patients 
from a regular secondary care outpatient department (RMHC group). The BIF and 
mild ID groups came from complete catchment area of  Rivierduinen and the RMHC 
group came from one particular region within this area (Katwijk, Zuid Holland, the 
Netherlands). Both groups consisted of  outpatients registered on January 1, 2011. 
In the RMHC group diagnoses were formulated using the DSM-IV-TR. In the BIF 
and mild ID groups DSM-IV-TR diagnoses were formulated using the DM-ID.9 
Where necessary the DM-ID offers supplements and adaptations for DSM-IV-TR 
diagnostic criteria and provides guidelines for making accurate psychiatric diagnoses in 
patients with various levels of  ID. For people with mild ID the DM-ID offers some 
special diagnostic considerations. Primary consideration is the developmental delay. 
Another consideration is to always take into account the context. The DM-ID stron-
gly recommends greater use of  behavioural observation and informant information 
in making a diagnosis of  PD. The DM-ID offers specific adaptations for diagnosing 
PD mainly for the age criterion. Because of  the developmental delay in ID the DM-
ID states that a diagnosis of  PD should only be considered provisionally before the 
individual is 21 years old. For individuals with BIF, diagnoses were formulated using 
the DSM-IV-TR but keeping in mind the same considerations concerning the deve-
lopmental perspective and context as for patients with mild ID. 
For inclusion and exclusion, see figures 1 and 2. Within our organization, patients 
with average or above average intellectual functioning with Pervasive Developmental 
Disorder (PDD) are referred to a special centre for autism spectrum disorders, while 
patients with a PDD and ID are referred to Kristal, Centre for Psychiatry and ID. 
Because patients with PDD were underrepresented in the RMHC group, leading to 
a possible bias when comparing the rates of  PD, patients with PDD were excluded 
from our analyses. In the excluded PDD group there were only 12 patients with a 
comorbid PD. The vast majority of  these patients (75%) had a PD Not Otherwise 
Specified (NOS). The final groups consisted of  235 patients with BIF (BIF group), 
1026 patients from RMHC (RMHC group), and 152 patients with mild ID (mild ID 
group).
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Figure 1. Inclusion flowchart CPID.
Figure 2. Inclusion flowchart RMHC.
599 patients registered at the two CPID
Diagnostic information available of
576 patients (96.1%)
511 patients diagnosed with
BIF or Mild ID (85.3%)
1254 patients registered at the RMHC
Diagnostic information available of 
1054 patients (84.0%)
1026 patients were included in the 
sample (81.8%)
28 patients were excluded:
Patients with BIF (1.1%)
Patients with PDD (1.1%)
387 patients were included in the 
sample (64.6%)
124 patients were excluded:
Patients with PDD (20.7%)
65 patients were excluded (10.6%):
Level ID unknown (2.3%)
Moderate ID (8.9%)
Severe ID (0.2%)
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Measures
Demographic variables and diagnostic categories
The following variables were collected for each patient from the electronic patient 
file: age, sex, level of  ID, and DSM-IV-TR axis II diagnoses. DSM-IV-TR axis I and II 
diagnoses recorded in the official registration system of  the electronic patient file were 
recorded. For analyses, the DSM-IV-TR diagnoses were categorized as follows: Cluster 
A PD (the “odd, eccentric” cluster, subdivided into paranoid, schizoid and schizotypal 
PD), Cluster B PD (the “dramatic, emotional erratic” cluster, subdivided into antiso-
cial, borderline, histrionic and narcissistic PD), cluster C PD (the “anxious, fearful” 
cluster, subdivided into avoidant, dependent and obsessive–compulsive PD) and PD 
not otherwise specified (NOS).
Intelligence
In the BIF and mild ID groups, level of  ID was based on IQ testing, using the WAIS-
III,10–12 in combination with multidisciplinary assessment of  present adaptive functio-
ning. Patients were divided into 2 groups according to DSM-IV-TR criteria based on 
TIQ and adaptive functioning: BIF (TIQ 70-85) and mild ID (TIQ 50-70). There was 
no IQ testing in the RMHC group.
Statistical analyses
Demographic and clinical variables were compared among the BIF group and the 
RMHC and mild ID groups, using analysis of  variance (ANOVA) for age and a 
Chi-square test for gender. All axis II were expressed in number and percentage. Dif-
ferences in axis II were compared using binary logistic regression. Odds ratios (OR) 
were calculated adjusted for sex and age. Within the BIF group we used a Chi-square 
and T-tests to analyse the association between gender and age and PD. All analyses 










      Male (%) 78 (33.2) 423 (41.2) 56 (36.8) 0.06
      Female (%) 157 (66.8) 603 (58.8) 96 (63.2)
Age (SD) 33.4 (12.5) 44.3 (16.6) 37.2 (13.6) <0.001
Table 1. Demographic characteristics among the BIF, RMHC and mild ID groups.
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Results
As shown in table 1. the RMHC group consisted of  1026 participants. A total of  235 
individuals was diagnosed with borderline intellectual functioning and 152 individuals 
were diagnosed with mild ID. The percentage of  females differed from 66.8% in the 
BIF group, 63.2% in the mild ID group and 58.8% in the RMHC group (χ²= 5.65, 
p= 0.06). Age difference was significant among the three groups with the mean age 
in the BIF group being 33.4, in the mild ID group 37.2 en in the RMHC group 44.3 
(p< 0.001). Because of  the differences among the groups in gender and age, ORs are 
adjusted for gender and age. Details of  the results are presented in Table 2. Summari-
zed, 52% (n= 124) of  the patients with BIF were diagnosed with a PD. PD NOS was 
the most frequently diagnosed PD (28.1%) in BIF followed by borderline PD (15.3%). 
Patients with BIF were more likely to be diagnosed with a PD than both the RHMC 
group (OR= 4.3, 95% CI 3.2-5.9) and the mild ID group (OR= 2.2, 95% CI 1.5-3.4). 
Compared to the RMHC group all rates of  PD diagnoses, except for cluster A PD, 
were increased in the BIF group. This increase was significant for cluster B PD (OR= 
2.44, 95% CI 1.56-3.81), especially borderline PD (OR= 2.3, 95% CI 1.43-3.73), clus-
ter C PD (OR= 2.45, 95% CI 1.34-4.49) and PD NOS (OR= 3.6, 95% CI 2.45-5.21). 
Compared to the mild ID group, rates of  all PD diagnoses expect for cluster A PD 
and histrionic PD were increased in the BIF group. This increase was significant for 
cluster C PD (OR= 3.54, 95% CI 1.2-10.7). 
The vast majority of  PD patients had one of  more comorbid axis I disorder. There 
was no significant difference in rates of  comorbid axis I disorders in the BIF group 
compared to RMHC (OR= 0.52, CI 0.23-1.15) or compared to the mild ID group 
(OR= 1.34 CI 0.57-3.16). Most prevalent axis I disorders in all three groups were 
Mood, Anxiety and Somatoform (MAS) disorders. 
Within the BIF group, there was no association found between gender and PD (χ²= 
2.92, p= 0.09) or between age and PD (p= 0.49, 95% CI -4.4 – 2.1).


















PD, all (%) 124 (52.8) 198 (19.3) 4.3 3.2-5.9** 51 (33.6) 2.2 1.5-3.4**
Cluster A (%) 0 (0) 2 (0.2) - - 0 (0) - -
   Paranoid PD 0 (0) 2 (0.2) - - 0 (0) - -
   Schizoid PD 0 (0) 0 (0) - - 0 (0) - -
   Schizotypal PD 0 (0) 0 (0) - - 0 (0) - -
Cluster B (%) 41 (17.4) 63 (6.1) 2.44 1.56-3.81** 14 (9.2) 1.86 0.96-3.6
   Antisocial PD 4 (1.7) 5 (0.5) 3.97 0.97-16.2 0 (0.0) - -
   Borderline PD 36 (15.3) 53 (5.2) 2.3 1.43-3.73** 12 (7.9) 1.9 0.92-3.8
   Histrionic PD 0 (0) 2 (0.2) - - 1 (0.7) - -
   Narcissistic PD 3 (1.3) 3 (0.3) 5.79 1.04-32.3** 1 (0.7) - -
Cluster C (%) 19 (8.1) 38 (3.7) 2.45 1.34-4.49** 4 (2.6) 3.54 1.2-10.7**
   Avoidant PD 6 (2.6) 21 (2.0) 1.09 0.42-2.83 2 (2.0) 1.3 0.32-5.38
   Dependent PD 11 (4.7) 13 (1.3) 4.78 1.96-11.65** 1 (0.7 7.96 1.0-62.9**
   OC PD 3 (1.3) 5 (0.5) 3.33 0.71-15.58 0 (0) - -
PD NOS (%) 66 (28.1) 101 (9.8) 3.6 2.48-5.21** 33 (21.7) 1.5 0.92-2.4
Comorbid 
Axis I
















Comorbid Axis I, 
all (%) 105 (84.7) 186 (93.9) 0.52 0.23-1.15 41 (80.4) 1.34 0.57-3.16
CI= Confidence Interval, BIF= borderline intellectual functioning, PD= Personality Disorder, ID= Intellectual Disability, NOS= 
Not Otherwise Specified  
* Odds Ratios adjusted for sex and age, ** Value 1 not in confidence interval, -Number too small for analyses
Table 2. Comparison of the rates of personality disorders (PD) among the borderline intellectu-
al functioning (BIF), regular mental health care (RMHC) and mild intellectual disability (Mild ID) 
groups using logistic regression corrected for sex and age. 
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Conclusion
The important finding of  this study is the high frequency of  PD diagnoses in BIF pa-
tients in daily clinical practice. Axis I and II DSM-IV-TR diagnoses of  235 outpatients 
with BIF were compared with 1026 outpatients from regular mental health care and 
152 mild ID outpatients. We found that over half  of  the patients with BIF (52.8%) 
were diagnosed with a PD, compared to one in five in the RMHC group (19,3%) and 
one in three of  de mild ID group (33.6%). All PD diagnoses, except for cluster A 
PD and histrionic PD, were most frequently diagnosed in the BIF group. PD NOS 
and borderline PD were the most frequently diagnosed PD in borderline intellectual 
functioning. The vast majority of  PD patients in all three groups had one of  more 
comorbid axis I disorder. MAS disorders were the most prevalent axis I disorders in 
all three groups. Within the BIF group no association was found between gender and 
age and PD. 
Even though there is growing evidence that low IQ is associated with increased risk 
of  and severity of  mental disorders including PD,8,13–16 our evidence based knowledge 
concerning PD in BIF is rudimentary. Up until now, in most countries BIF is scar-
cely even recognized in outpatients in mental health care. This, in spite of  the fact 
that evidence increasingly shows that many people with BIF face major difficulties 
across their life courses including several risk factors for the development of  mental 
health problems.7,17 People with BIF are more likely to experience child hood trauma, 
have more psychosocial problems and are less likely to have adequate support sys-
tems,2,7,18–20 all risk factors for the development of  a PD. 
Having a PD with concurrent BIF is likely to influence treatment and prognosis. At 
this time, in most places, adults with BIF and concurrent mental health problems are 
less likely to receive treatment of  any kind.8 If  they do receive treatment they are more 
likely to receive psychopharmacological treatment and less likely to receive counsel-
ling or psychological interventions.8 This is in contrast with all the evidence based 
treatments available for patients with PD and average intelligence, like Dialectical 
Behaviour Therapy (DBT)21–23 and Mentalisation Based Therapy (MBT).24–26 It is also 
in contrast with the growing evidence on treatments for patients with PD and ID, like 
DBT.27,28 
There are several strengths in the present study. First, this study examines a large sam-
ple of  patients with borderline intellectual functioning, which is a hidden population 
in mental health care in most countries. Second, the label of  BIF was always carefully 
applied and recently established, based on formal IQ testing using the standardized 
Wechsler Adult Intelligence Scale (WAIS-III). This holds also true for the label of  
mild ID. Third, PD diagnoses were the diagnoses as recorded in the official registrati-
on system of  the electronic patient file, making this study a reflection of  actual daily 
clinical practice. Patients with BIF and mild ID were assessed multidisciplinary, accor-
ding to a strict protocol based and PD diagnoses were made following DM-ID guide-
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lines.9 Fourth, the fact that the findings are based on large samples from a naturalistic 
outpatient setting makes them generalizable to the clinical field of  interest. 
However, the results should also be interpreted in the light of  some limitations. First, 
issues of  referral may have introduced bias. Even though referral pathways are well 
established, not all patients with BIF receive specialised outpatient psychiatric treat-
ment. There might be individuals with unidentified BIF in regular psychiatric services. 
Second, in both the BIF and mild ID groups there were many patients diagnosed 
with PDD because of  a special referral policy. They were excluded from analysis, 
which means that part of  the initial sample was not included. However, most patients 
diagnosed with PDD were not diagnosed with any co-morbid PD, so the extent of  
the introduced bias probably is small. A third limitation is that results apply only to 
outpatients and cannot be generalized to more severely ill in-patients. Fourth, there 
was no IQ testing in the RMHC group. Fifth, demographic information was limited 
and information on treatment was not available. 
In conclusion, there is a high frequency of  PD diagnoses in BIF outpatients in daily 
clinical practice. In anticipation of  further scientific research, results suggest that PD 
should not be overlooked in patients with BIF.
Chapter 4 The prevalence of personality disorders in psychiatric outpatients with BIF 49
References 
1. Salvador-Carulla L, García-Gutiérrez JC, Ruiz Gutiérrez-Colosía M, et al. Borderline intel-
lectual functioning: consensus and good practice guidelines. Rev Psiquiatr y salud Ment. 
2013;6(3):109-120. 
2. Wieland J, Haan SK, Zitman FG. Psychiatric Disorders in Outpatients With Borderline Intellec-
tual Functioning : Comparison With Both Outpatients From Regular Mental Health Care and 
Outpatients With Mild Intellectual Disabilities. 2014;59(4):213-219.
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th 
edn, Text Revision)(DSM-IV-TR). Washington D.C.;2000. 
4. American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders 
(5th edn)(DSM-5). Washington, DC; 2013.
5. WHO. International Statistical Classification of Diseases and Related Health Problems (Internatio-
nal Classification of Diseases)(ICD 10th Revision - Version:2010). Geneva; 2010.
6. Hassiotis A, Ukoumunne OC, Byford S, et al. Intellectual functioning and outcome of patients 
with severe psychotic illness randomised to intensive case management. Report from the UK 
700 trial. Br J Psychiatry. 2001;178:166-171. 
7. Seltzer MM, Floyd F, Greenberg J, Lounds J, Lindstromm M, Hong J. Life course impacts of mild 
intellectual deficits. Am J Ment Retard. 2005;110(6):451-468. 
8. Hassiotis A, Strydom A, Hall I. Psychiatric morbidity and social functioning among adults with 
borderline intelligence living in private households. J Intellect Disabil Res. 2008;52(2):95-106.
9. Fletcher R, Loschen E, Stavrakaki C. DM-ID: diagnostic manual-intellectual disability: a text-
book of diagnosis of mental disorders in persons with intellectual disability. New York, NADD; 
2007.
10. Wechsler D. WAIS‐III. Administration and scoring manual. Psychol Corp San Antonio, TX. 1997.
11. Wechsler D. WAIS-III. Nederlandstalige Bewerking: Afname en Scoringshandleiding. Swets & 
Zeitlinger, Lisse; 2000. 
12. Tellegen P. De betrouwbaarheid en validiteit van de WAIS-III NL. De Psycholoog. 2003;128-132.
13. Gigi K, Werbeloff N, Goldberg S, et al. Borderline intellectual functioning is associated with 
poor social functioning , increased rates of psychiatric diagnosis and drug use – A cross sectio-
nal population based study. Eur Neuropsychopharmacol. 2014;24(11):1793-1797. 
14. Stratta P, Riccardi I. Premorbid intelligence of inpatients with different psychiatric diagnoses 
does not differ. Neuropsychiatr Dis Treat. 2008;4:1241-1244.
15. Urfer-Parnas a, Lykke Mortensen E, Saebye D, Parnas J. Pre-morbid IQ in mental disorders: a 
Danish draft-board study of 7486 psychiatric patients. Psychol Med. 2010;40(4):547-556. 
16. Wieland J, Wardenaar KJ, Fontein E, Zitman FG. Utility of the Brief Symptom Inventory (BSI) in 
psychiatric outpatients with intellectual disabilities. J Intellect Disabil Res. 2012;56(9):843-853. 
17. Peltopuro M, Ahonen T, Kaartinen J, Seppälä H, Närhi V. Borderline Intellectual Functioning: A 
Systematic Literature Review. Intellect Dev Disabil. 2014;52(6):419-443.
18. Johnson J, Cohen P. Childhood maltreatment increases risk for personality disorders during 
early adulthood. Arch Gen Psych. 1999;56:600-606. 
50 Psychopathology in borderline intellectual functioning
19. Coid J. Epidemiology, public health and the problem of personality disorder. Br J Psychiatry. 
2003;182:s3-s10.
20. Berlo W Van, Haas S De, Oosten N Van. Een onderzoek naar seksueel geweld bij mensen met 
een lichamelijke, zintuiglijke of verstandelijke beperking. Rutgers WPF. 2011.
21. Linehan M. Dialectical Behavior Therapy for borderline personality disorder: Theory and me-
thod. Bull Menninger Clin. 1987. 
22. Soler J, Pascual J. Double-blind, placebo-controlled study of dialectical behavior therapy plus 
olanzapine for borderline personality disorder. Am J Psychiatry. 2005;162:1221-1224. 
23. McMain S, Links P. A randomized trial of dialectical behavior therapy versus general psychia-
tric management for borderline personality disorder. Am J Psychiatry. 2009;166:1365-1674. 
24. Allen J, Fonagy P. The Handbook of Mentalization-Based Treatment. John Wiley & Sons; 2006. 
25. Bateman A, Fonagy P. 8-year follow-up of patients treated for borderline personality disorder: 
mentalization-based treatment versus treatment as usual. Am J Psychiatry. 2008;165:631-638. 
26. Bateman A, Fonagy P. Randomized controlled trial of outpatient mentalization-based 
treatment versus structured clinical management for borderline personality disorder. Am J 
Psychiatry. 2009;166:1355-1366. 
27. Lew M, Matta C, Tripp-Tebo C, Watts D. Dialectical behavior therapy (DBT) for individuals with 
intellectual disabilities: A program description. Ment Heal Asp. 2006;9:1-13. 
28. Brown J, Brown M, Dibiasio P. Treating individuals with intellectual disabilities and challenging 
behaviors with adapted dialectical behavior therapy. J Ment Heal. 2013;6:280-303.
Chapter 5
Utility of the brief symptom inventory 






Journal of Intellectual Disability Research 2012;56(9):843-853
52 Psychopathology in borderline intellectual functioning
Abstract
Background Diagnostics and care for people with intellectual disabilities and psy-
chiatric disorders need to be improved. This can be done by using assessment instru-
ments to routinely measure the nature and severity of  psychiatric symptoms. Up until 
now, in the Netherlands, assessment measures are seldom used in the psychiatric care 
for this population.
The objective of  the present paper is to evaluate the use of  the BSI, a widely used 
standardised questionnaire in general psychiatry, in a well-defined sample of  people 
with borderline intellectual functioning (BIF) or mild intellectual disabilities (ID) diag-
nosed with one or more psychiatric disorders.
Method A total of  224 psychiatric outpatients with either BIF or mild ID participa-
ted in this study. All participants were new patients of  the two Centres for Psychiatry 
and Intellectual Disability (CPID) of  Rivierduinen, a large regional mental health care 
provider in the Netherlands, in the period between April 1 2008 and October 1 2009. 
All participants were assessed by a multidisciplinary team. DSM-IV-TR criteria were 
applied. The mean total intelligence coefficient (TIQ) was measured with the Wechsler 
Adult Intelligence Scale (WAIS-III). The BSI was administered in an assisted fashion. 
Psychometric properties of  the BSI were investigated. Bivariate correlations between 
the subscales were computed to assess differentiation between the scales and mean 
subscale scores were compared between different DSM-IV-TR subgroups to investiga-
te the discriminant abilities of  the scales. A confirmatory factor analysis was conduc-
ted. 
Results The results suggest that the BSI is practically useful. Internal consistencies 
ranged from 0.70 – 0.96 and thus are considered good to adequate. Subscale inter-
correlations showed there is a degree of  differentiation between the subscales. Dis-
criminant validity was shown for the subscales Depression, Anxiety and Phobic anxiety. 
Confirmatory factor analysis showed that de underlying structure of  the BSI could be 
described by the same 9-factor model as reported in previous studies.
 
Conclusions As a result of  the psychometric properties illustrated, this study sup-
ports the use of  the BSI as a screener for psychopathology and a general outcome 
measure in people with intellectual disabilities. 
Chapter 5 Utility of the BSI in psychiatric outpatients with intellectual disabilities 53
Introduction 
It is commonly known by now that people with intellectual disabilities (ID) experien-
ce the full range of  psychiatric disorders. And even though prevalence rates vary, in 
most studies, they turn out much higher than in the general population.1–8 In contrast, 
psychiatric diagnoses are often missed and little is known about the effectiveness of  
treatment of  psychiatric disorders in this population.4,7,9 Therefore diagnostics and 
care for people with ID and psychiatric disorders need to be improved. This can be 
done by using assessment instruments to routinely measure the nature and severity of  
psychiatric symptoms. 
In the Netherlands, assessment measures are seldom used in the psychiatric care for 
this population. This is at least in part due to the lack of  adequately translated and 
tested assessment instruments in the Dutch language.
In the Dutch language there are only a few measures available specially developed for 
people with ID and little is known about the utility of  existing ‘regular’ assessment 
measures. This is especially true for self-report measures. 
Using self–report measures may present challenges due to language and memory pro-
blems, a reduced ability to conceptualize and express emotions, as well as due to social 
desirability.7,10 
However, people with borderline intellectual functioning (BIF) or mild ID are general-
ly quite capable of  reporting about their own behaviours and feelings.11–15 
If  self-report measures are used, they are usually developed or modified for people 
with ID, but with little attention paid to psychometric properties and comparability 
with existing psychiatric ratings.16 
One could argue, as did Kellett et al.,17 that it is ethically and theoretically more appro-
priate to explore the application of  existing non-altered assessment measures before 
modifying existing, or developing new instruments.
Examples of  existing self-report measures from general psychiatry already researched 
for their use in people with ID are the Beck Depression Inventory and the Zung Self- 
Rating Depression Scale,18 the Beck Anxiety Inventory,19 the Zung Self-Rating Anxiety 
Scale,12 and the Hospital Anxiety and Depression Scale.20 Although more research is 
needed, all authors stress the applicability and potential utility of  these instruments in 
people with ID.
Kellett et al.21,22 evaluated the use of  the Brief  Symptom Inventory (BSI), a widely 
used assessment measure in the general psychiatry, in people with ID in the United 
Kingdom. Their first study consisted of  200 mild ID participants from three distinct 
groups: a clinical, a community and a forensic group. The second study consisted of  
335 participants, all diagnosed with mild ID, but with no reference of  psychopatho-
logy.
Kellett et al.21,22 found that people with ID respond to most questions of  the BSI in 
a similar way as do people without ID and that internal consistency of  the different 
subscales was satisfactory. Moreover they concluded, in their first study, that the BSI 
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could effectively discriminate between the different groups. They concluded that the 
BSI can be employed as an assessment instrument and as a treatment outcome measu-
re in people with ID. 
The objective of  the present paper was to further extend the research on the utility 
of  the BSI in a well-defined sample of  people with BIF or mild ID. In view of  the 
findings of  Kellett et al.21,22 it is reasonable to hypothesize that the BSI has adequate 
psychometric properties and can be used in this population.
Method
Participants
A total of  224 people participated in the study. All participants were new patients of  
one of  the two Centres for Psychiatry and Intellectual Disability (CPID) of  Rivierdui-
nen, a large regional mental health care provider in the Netherlands, between April 1 
2008 and October 1 2009. All participants were assessed by a multidisciplinary team, 
including a certified psychiatrist, and were classified according to the criteria of  the 
Diagnostic and Statistical Manual of  mental disorders (DSM-IV-TR) with either BIF 
or mild ID. In addition, 92.9% were classified with one or more DSM-IV-TR psychi-
atric disorders. Intelligence could be assessed in 205 (91.5 %) participants. The mean 
total intelligence coefficient (TIQ), measured with the Wechsler Adult Intelligence 
Scale (WAIS-III), was 71 (SD=8.1; range 50-87). 44.6% of  participants were diagno-
sed with a mild ID; 53.9% with BIF. Two people had a TIQ of  respectively 86 and 87. 
TIQ could not be obtained for 19 participants, either because no IQ-test was adminis-
tered (13 cases) or because the discrepancy between verbal and performal IQ was too 
large to make a reliable statement about the total IQ score (6 cases). 
Instrument
The Brief  Symptom Inventory (BSI)23 is a essentially the brief  form of  the SCL-90-R, 
a self-report inventory that has been developed and used in a wide variety of  settings 
and applications.24,25 It is a self-report (or interview administered) symptom scale 
consisting of  53 items, covering nine symptom dimensions: Somatisation (SOM), Ob-
session-Compulsion (O-C), Interpersonal Sensitivity (I-S), Depression (DEP), Anxiety (ANX), 
Hostility (HOS), Phobic anxiety (PHOB), Paranoid ideation (PAR) and Psychoticism (PSY). 
Each item is ranked on a 5-point Likert scale ranging from 0 (not at all) to 4 (extreme-
ly). Rankings characterize the intensity of  distress during the past seven days. Next to 
scores on all of  the nine symptom dimensions, 3 global indices of  severity of  psycho-
pathology can be calculated: The average score on all 53 items together, the number 
of  items with non-zero responses (or: the number of  symptoms experienced by the 
respondent) and the severity of  the existing symptoms (or: the total score divided by 
the number of  symptoms experienced by the respondent).26
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Several studies have shown the BSI to have adequate internal consistency in the gene-
ral population. Cronbach’s alphas of  the original American version of  the BSI range 
from 0.71 (PSY) to 0.85 (DEP), with 4 out of  9 scales having an alpha over 0.80.27,28 
Also the BSI had adequate construct validity: a 9-factor structure.27,29
In Kellett’s study21 of  ID patient population, the Cronbach’s alphas for all participants 
(all three groups included) ranged from 0.63 (PSY) to 0.78 (O-C). Using normal vari-
max rotation Kellett et al.22 derived 8 interpretable factors. However they also found a 
marked degree of  overlap with the existing BSI factor structure.
De Beurs & Zitman30 translated the BSI in Dutch. They did a large-scale evaluation of  
the BSI and found that the reliability of  the different subscales of  the Dutch version 
of  the BSI was good and that the convergent and divergent validity was adequate. The 
Dutch translation of  the BSI showed Cronbach’s alphas of  0.71 (PSY) to 0.87 (DEP 
and ANX), with 8 out of  9 scales having an alpha over 0.80, and the same 9-factor 
structure. De Beurs & Zitman30 concluded that the BSI is an excellent screener for 
psychopathology and a good general outcome measure.   
Procedure
The BSI was administered in an assisted fashion, much like the “assisted completion 
format” for the SCL-90 as described by Kellett et al.17,21 They concluded that the assis-
ted completion format was shown not to influence respondents’ ratings of  symptoms 
excessively and did not affect the psychometric properties of  the test.17,21 
Our assisted administration consisted of  the following: The assessment was conduc-
ted in a one-to-one setting. Both the instruction and the items of  the BSI were read 
in order. The items were either read together with the respondent or verbatim to the 
respondent. The answer feedback sheet contained both numerical and grammatical 
representations. Language was adapted when needed, meaning that the same item was 
repeated in simplified wordings. Using this format, administration time was between 
10 and 30 minutes, on average 20 minutes.
A list of  difficult items was kept for part of  the sample (n= 43). A question was con-
sidered difficult when either the respondent indicated not understanding the question 
completely, or when the administrator noted that the question was not understood 
properly. The latter was confirmed by asking the respondent to rephrase the question 
in his or her own words. Afterwards items were explained as needed. 
Statistical analyses
To investigate the utility of  the BSI in our patient group, for each item, the number 
of  times an item needed explaining was counted to identify difficult items. To inves-
tigate the role of  intelligence for ease of  administration, a regression analysis was 
conducted with the number of  items that needed explaining as dependent variable 
and TIQ as independent variable. For each item the distribution of  responses on the 
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Likert-scale was inspected to identify possible response tendencies. Several additional 
analyses were conducted to investigate the psychometric characteristics. First, internal 
consistency coefficients (Cronbach’s alphas) were computed for the total scale and 
the subscales. Second, bivariate correlations between the subscales were computed to 
assess differentiation between the scales. Third, mean subscale scores were compared 
between different DSM-IV-TR subgroups to investigate the discriminant abilities of  
the scales. Fourth, confirmatory factor analysis (CFA) was conducted to investigate 
whether the previously identified 9-factor structure23 fit to our data. Because the items 
were categorical and non-normal, robust maximum likelihood fit-estimations31 were 
used, based on a polychoric correlation matrix32. Model-fit was investigated with fit-in-
dices instead of  a traditional χ²-test, because the latter is oversensitive to minor devi-
ations from perfect model-fit for complex model.33 The used fit robust indices were: 
the normed fit index (NFI), the comparative fit index (CFI) and the root mean square 
error of  approximation (RMSEA). An NFI and CFI of  at least 0.90 indicate adequate 
fit (≥0.95 indicates good fit) and an RMSEA smaller than 0.06 indicates good fit. Ana-
lyses were conducted with the SPSS version 16.0 (SPSS Inc, Chicago, IL) and EQS 6.1 
(Multivariate Software inc., Encino, California, USA) software packages.
Ethical Considerations and privacy issues
Within the regional mental health care organisation Rivierduinen, it is part of  the 
general policy to monitor treatment outcome using a method called ROM (Routine 
Outcome Monitoring).34 The two CPID of  Rivierduinen have their own form of  
ROM, using instruments especially developed for people with ID and instruments 
from regular psychiatry such as the BSI. People are informed at the beginning of  the 
assessment that if  data from these instruments is used for research purposes, this 
is done in anonymous form. If  people object to such use, their data is removed. A 
comprehensive protocol safeguards anonymity of  the patients and ensures proper 
handling of  the data. This protocol is available for patients on request. The Medical 
Ethical Committee of  the Leiden University Medical Centre (LUMC) approved the 
regulations and agreed with this policy.34
Results
       
Descriptive and diagnostic information
Both the descriptive and diagnostic information about the study group are shown in 
Table 1. There were 136 (60.7%) women and the mean age was 32.2 (Standard Devi-
ation (SD)= 12.1; range 16-71). The TIQ had a mean of  71.3 (SD= 8.3) and ranged 
from 50 to 87. The large majority (92.3%) of  the group had a broad variety of  DSM-
IV-TR diagnoses. Most prevalent were anxiety disorders, which were present in 17.9% 
of  the patients and pervasive developmental disorders (PDD) (17.9%), followed by 
posttraumatic stress disorders (PTSD) (12.9%), ADHD or ADD and disruptive beha-
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viour disorders (9.8%) and mood disorders (9.4%). A DSM-IV-TR personality disor-
der (PD) was diagnosed in a total 25.4% of  all patients. Of  those patients diagnosed 
with a PD, almost half  (47%) was also diagnosed with an axis I disorder. Not taking 
into account classifications for BIF and ID, 24.6% of  participants had two psychiatric 
diagnoses and 6.7% had three or more psychiatric diagnoses.
Descriptive information
   Female (%) 136 (60.7%)
   Male (%) 88 (39.3%)
   Mean age (SD) 32.2 (12.1)
   Age range 16-71
   Mean TIQ (SD) 71.3 (8.3)
   TIQ range 50-87
Axis I diagnoses (DSM-IV-TR)
   Pervasive developmental disorders 40 (17.9%)
   Mood disorders 21 (9.4%)
   Anxiety disorders 40 (17.9%)
   Somatoform disorders 7 (3.1%)
   Posttraumatic stress disorder 29 (12.9%)
   ADHD, ADD and disruptive behaviour disorder 22 (9.8%)
   Psychotic disorders 9 (4.0%)
   Addictive disorders 15 (6.7%)
   Adjustment disorders 17 (7.6%)
   Other* 61 (29.0%)
Personality Disorders (DSM-IV-TR)
   Borderline 15 (6.7%)
   Other** 10 (4.4%)
   Not Otherwise Specified 33 (14.7%)
No DSM-IV-TR diagnosis 17 (7.6%)
TIQ= total intelligence quotient, ADHD= Attention-Deficit Hyperactivity-Disorder, 
ADD= Attention Deficit Disorder, *mainly DSM-IV-TR V-codes, **This group includes mostly 
cluster C, dependent and avoidant personality disorders
Table 1. Demographic and psychopathology information in a sample of psychiatric outpatients 
with BIF or mild ID (n= 224).
Practical utility 
A list of  difficult questions was kept for part of  the sample (n= 43). The mean num-
ber of  questions that needed explaining was 3.9 (SD= 3.6). Only 14.0% of  partici-
pants needed 6 or more questions explained to them. And 51.2% of  participants nee-
ded explaining of  only 3 questions or less. Also, 16 (30.0%) of  the 53 BSI items were 
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understood by all participants. Only 4 items needed explaining in more than a third of  
cases. Those items were The idea that someone else can control your thoughts (item 
3), Feeling blocked in getting things done (item 15), Your mind going black (items 32) 
and Never feeling close to another person (item 44). A regression analysis showed that 
there was an association between the number of  explained items and TIQ (regression 
coefficient (b)= -0.19; p= 0.007). These results indicate that TIQ plays a role in the 
number of  items needing explanation: with an increase of  roughly 5 points in TIQ, 
the number of  explained items decreases with (0.19*5≈) 1.
Internal consistency
The internal consistency of  the BSI was calculated using Cronbach’s coefficient alpha. 
The number of  items and internal consistencies of  the different BSI subscales are gi-
ven in Table 2. Alpha coefficients of  the different subscales ranged from 0.70 to 0.86 
and alpha was 0.96 for the BSI-total. For 5 subscales, coefficient alpha exceeded 0.80, 
which indicates good internal consistency. The other 4 subscales all had alpha coeffi-
cients exceeding 0.70, which is considered adequate. 
Table 2. Description of the Brief Symptom Inventory (sub)scales and their Cronbach’s alpha coeffi-
cients in a sample of psychiatric outpatients with BIF or mild ID (n= 224).
BSI scale Description Included item numbers  Cronbach’s α
SOM Somatic complaints 2, 7, 23, 29, 30, 33, 37 0.83
O-C Obsession-compulsion 5, 15, 26, 27, 32, 36 0.81
I-S Interpersonal Sensitivity 20, 21, 22, 42 0.80
DEP Depression 9, 16, 17, 18, 35, 50 0.86
ANX Anxiety 1, 12, 19, 38, 45, 49 0.82
HOS Hostility 6, 13, 40, 41, 46 0.78
PHOB Phobic anxiety 8, 28, 31, 43, 47 0.78
PAR Paranoid ideation 4, 10, 24, 48, 51 0.77
PSY Psychoticism 3, 14, 34, 44, 53 0.70
BSI Total Brief Symptom Inventory Total score 1-53 0.96
All alpha coefficients that indicate good internal consistency are printed in bold font; all alpha coefficients that indicate ade-
quate internal consistency are printed in italic font
Subscale intercorrelations
To investigate the relationships between the different BSI subscales, bivariate corre-
lations were computed. The correlation coefficients are shown in Table 3 and ranged 
from 0.39 to 0.79, which indicates that there are different inter-scale relations. For 
instance, the DEP subscale showed substantial correlations with the PSY scale (r= 
0.79) and the I-S scale (r= 0.70) and somewhat lower correlations with the HOS scale 
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(r= 0.45), the SOM scale (r= 0.54) and the ANX scale (r= 0.64). In addition, the 
ANX scale showed its most substantial correlation with the PHOB scale (r= 0.73). 
The SOM scale showed its strongest correlation with the ANX scale (r= 0.62). These 
results indicate that there is a degree of  differentiation between these subscales, based 
on their content.
Table 3. Inter-correlations of the Brief Symptom Inventory (sub)scales in a sample of psychiatric 
outpatients with BIF or mild ID (n=223).
BSI scale SOM O-C I-S DEP ANX HOS PHOB PAR PSY
SOM 0.83 - - - - - - - -
O-C 0.56 0.81 - - - - - - -
I-S 0.48 0.69 0.80 - - - - - -
DEP 0.54 0.67 0.70 0.86 - - - - -
ANX 0.62 0.68 0.66 0.64 0.82 - - - -
HOS 0.39 0.45 0.51 0.45 0.54 0.78 - - -
PHOB 0.58 0.62 0.71 0.61 0.73 0.42 0.78 - -
PAR 0.56 0.67 0.66 0.67 0.60 0.58 0.58 0.77 -
PSY 0.52 0.67 0.71 0.79 0.66 0.37 0.71 0.65 0.70
The coefficients are Pearson bivariate correlation coefficients; underlined numbers correspond to the Cronbach’s alpha coeffi-
cients of the subscales
Discriminant validity
To investigate discriminant validity, mean subscale scores and BSI Total were compa-
red between groups with- and without a DSM-IV-TR disorder and between groups 
with different DSM-IV-TR diagnoses. The mean BSI Total scores are shown in Figure 
1. Subjects with DSM-IV-TR axis-I (Mean BSI Total score= 1.10) disorders had 
higher total scores than subjects without a diagnosis (Mean BSI Total Score= 0.72; 
p= 0.03). Patients diagnosed with a PD or both an axis-I and a PD (Mean BSI Total 
score= 1.51) scored much higher than patients with only axis-I disorders (p= 0.001). 
Interestingly, patients diagnosed with an autism spectrum disorder scored lower (mean 
BSI Total score= 0.78) than other patients (p< 0.001) and had a mean score that was 
similar to subjects without a DSM-IV-TR disorder. At the subscale level, patients 
with a DSM-IV-TR diagnosis had significantly higher scores on all of  the subscales 
than subjects without a diagnosis, except for phobic anxiety (p= 0.13). When patients 
with PDD were left out of  the analyses, the differences between subjects with and 
without a DSM-IV-TR diagnosis on each of  the BSI-subscales all became significant. 
To investigate the discriminative validity of  some of  the subscales, mean scores were 
compared between patients with a mood, anxiety or somatoform disorder. Patients 
with a major depressive disorder (MDD) scored significantly higher on the DEP sub-
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scale (mean 1.79) than patients with other disorders (mean 1.21; p= 0.02); see Figure 
2. Patients diagnosed with an anxiety disorder scored significantly higher on the ANX 
subscale and on the PHOB subscale (mean ANX 1.71; mean PHOB 1.28) than pa-
tients with other disorders (mean ANX 1.19; mean PHOB 0.87; respectively: p= 0.005 
and p= 0.035); see Figure 3. Patients with a somatoform disorder scored higher on the 
SOM subscale (mean 1.24) than patients with other disorders (mean 0.89); see Figure 
4. However, this difference was not statistically significant (p= 0.43), likely due to the 
small group-size (n= 7). Taken together, these results indicate that the DEP, ANX, 
PHOB and maybe SOM subscales have the ability to discriminate between different 
DSM-IV-TR diagnoses.
Figure 1. Mean total Brief Symptom Inventory scores for subjects without a psychiatric diagnosis 
(n=17), patients with an axis I diagnosis (n=150), patients with an axis II diagnosis (n=59) and 
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Figure 2. Mean scores on the Brief Symptom Inventory DEP-subscale for subjects with and 












































Figure 3. Mean subscale scores on the ANX and PHO subscales of the Brief Symptom Inventory for 
subjects with and without an anxiety disorder. Error bars indicate standard errors.
Figure 4. Mean scores on the Brief Symptom Inventory SOM scale for subjects with or without a 
current somatoform disorder. Error bars indicate standard errors.
Facture structure
To investigate whether the 9-factor structure of  the original BSI also fit to the BSI-da-
ta from the current ID group, a CFA was conducted. The NFI was 0.94, the CFI was 
0.98 and the RMSEA was 0.048 (90% CI 0.043-0.053), which all indicated the model 
to fit well to the data. These results indicate that the underlying structure of  the BSI in 
the current study can be described by the same 9-factor model, as reported in previ-
ous studies.
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Discussion
The present study investigated the practical utility and different psychometric aspects 
of  the BSI when applied in people with BIF or mild ID. The results suggest that the 
BSI is practically useful and has adequate internal consistency and validity. These 
results have several interesting implications. 
Our study especially demonstrated the practical utility of  the BSI. Even though Dero-
gatis27 didn’t intend the BSI to be used in people with ID, using the BSI in people with 
below average intelligence turned out to be not as difficult as previously thought. Most 
questions of  the BSI were easily understood by most participants. On average only 4 
questions needed explaining. This is about 7.5% of  the total of  53 questions. There 
was a relation between TIQ and the number of  questions participants found difficult. 
With a decrease of  roughly 5 points in TIQ, one more item of  the BSI needed explai-
ning. 
Concerning the psychometric properties, it can be reported that internal consistencies 
across the different subscales were good to adequate. The Cronbach’s alphas obtain-
ed (0.70-0.86) were quite similar to the Cronbach’s alphas of  the original published 
norms (0.71-0.85)26 and the study by De Beurs & Zitman30 in a large Dutch non-disa-
bled sample (0.71-0.87) and not very dissimilar from the alphas in the study of  Kellett 
et al.21(0.63-0.78).
Construct and discriminant validity was comparable to those in other non-disabled as 
well disabled populations.21,30 The factor structure of  the BSI indicated that the under-
lying structure of  the BSI in the current study can be described by the same 9-factor 
model, as reported in previous studies.23,30 And even though Kellett et al.22, using 
normal varimax rotation, derived only 8 interpretable factors, they did find a marked 
degree of  overlap with the existing BSI factor structure. 
Kellett et al.21 already demonstrated that the BSI could reliably discriminate between a 
clinical, a community and a forensic group. In terms of  clinical utility and discriminant 
validity, the present study also demonstrated that patients diagnosed with a psychia-
tric disorder had a significantly higher BSI Total score compared to those without a 
psychiatric diagnosis. Patients had significantly higher scores on all of  the subscales 
except Phobic anxiety. The BSI could reliably distinguish between patients with either 
a MDD or other disorder, using the scores on the Depression subscale. The same 
holds true for people with an anxiety disorder, using the scores on the Anxiety and 
Phobic anxiety subscales. For the Somatisation subscale there was a tendency, however 
statistically insignificant, to distinguish between people diagnosed with a somatoform 
disorder and those diagnosed with other psychiatric disorders. Important to note is 
the fact that people with PDD scored significantly lower than other patients on all 
subscales of  the BSI and comparable to people without a psychiatric diagnosis. This is 
likely because the problems generally experienced by people with PDD (qualitative im-
pairment in social interaction and communication and restricted repetitive and stereo-
typed patterns of  behaviour, interests and activities) are not reflected in the different 
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items of  the BSI. Therefore the BSI might not be of  use in people with PDD. Ano-
ther finding was that patients diagnosed with a (co-morbid) PD, scored above aver-
age on all the subscales of  the BSI. This difference was significant for 7 out of  9 of  
the BSI subscales including the BSI Total. One could hypothesize, that patients with 
(co-morbid) PD score above average compared to patients with only axis I disorders 
because they experience a lot of  emotional dysregulation and interpersonal problems, 
and will recognize themselves in many items of  the BSI. This of  course applies mostly 
to patients with cluster B personality traits, which was the cluster of  personality traits 
mostly seen in our sample. We found a prevalence rate of  PD of  25.4%. This may 
seem high, but it is in accordance with findings in other studies. Corbett35 found a 
prevalence of  PD of  25.4% in a sample of  402 participants. Eaton & Menolascino36 
found a prevalence rate of  27.1% in a community-based sample of  115 people. And 
in a population of  100 individuals, with mild or moderate ID, Reid & Ballinger37 found 
a prevalence rate of  22%. Khan et al.38 even reported a warranted personality diagno-
sis in 31% of  their community sample. 
On a more general note it should be said that in the Dutch version of  the BSI the di-
mension of  Obsession-Compulsion (O-C) was translated in Problems in Cognitive Functioning, 
because next to obsessive-compulsive symptoms, this dimension also measures – for 
instance – concentration loss.30 This re-titling was also proposed by Kellett et al.22, 
who argued that the scale’s item constructions appeared to reflect traditional cognitive 
difficulties reported by people with ID, rather than obsessive-compulsive sympto-
matology. Limitations of  the present study include the fact that the results from the 
present outpatient population cannot without further research be generalised to an 
inpatient population. Also there is a lack of  data comparing the assisted completion 
format with the self-report format. But, not only would this comparison be hard to 
make, the assisted completion format did not harm the psychometric integrity and was 
shown by Kellett et al.17,21 not to influence respondents’ ratings of  symptoms excessi-
vely. Evidently more research is needed concerning reliability (e.g. test-retest reliability) 
and convergent and divergent validity of  the BSI in intellectually disabled populations. 
In conclusion, as a result of  the psychometric properties illustrated, this study sup-
ports the use of  the BSI as a screener for psychopathology and a general outcome 
measure in people with BIF or ID. 
Because of  the nature of  this study, we are hopeful that results will also apply to other 
intellectually disabled psychiatric outpatient populations. One advantage of  the BSI 
is that it can be used in many patients across a wide range of  symptoms and diagno-
ses.e.g.21,30,39–41 Another advantage is that it can be applied across different therapeutic 
interventions (e.g. pharmacotherapy, cognitive behavioural therapy).42–44
A more general implication of  the present study should be that other self-report 
measures developed for the general psychiatric population might also be of  use with 
patients with BIF or ID. Even though this should not be done without special atten-
tion for the psychometric properties in this population, using assessment measures 
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from general psychiatry could greatly increase the number of  available assessment 
instruments for these patient populations. This in turn will allow for routinely mea-
suring the nature and severity of  psychiatric symptoms or Routine Outcome Monito-
ring (ROM) in this population. 
ROM is a method for the systematic use of  assessment instruments for collecting 
information about patients.45 In the Netherlands ROM is used in a growing num-
ber of  mental health care organisations. First, in addition to the clinical interview, to 
establish the nature and severity of  symptoms at baseline or first presentation. This is 
important for making the right treatment decisions. Second ROM is used to establish 
the course of  symptoms over time, visualizing the effect of  the treatment, both on 
an individual level as well as on group level (for instance all people being treated in a 
certain way or all people suffering from the same mental illness). An important part of  
routine outcome monitoring is the fact that the system allows for feedback to treating 
psychiatrists, psychologist and other health care practitioners, allowing them to talk 
about the effect of  the treatment with their patients and thus use the results therapeu-
tically.45 Using ROM in people with BIF and ID will improve psychiatric diagnostics 
and care and using instruments like the BSI will make ROM possible in this popula-
tion. 
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Abstract
Introduction In most countries, people with borderline intellectual functioning (BIF) 
are not considered a separate group in mental health care. There is little to no 
research on the impact of  BIF on the presentation, nature and severity of  mental 
health problems. The aim of  the present exploratory study was to compare, in a 
naturalistic setting of  patients referred to secondary care, symptom profiles of  pa-
tients with BIF diagnosed with either major depressive disorder (MDD) or posttrau-
matic stress disorder (PTSD) to patients from regular mental health care (RMHC) and 
patients with mild ID diagnosed with the same disorders. 
Methods We used a cohort of  adolescent and adult outpatients (aged 16 to 88) with 
or without BIF diagnosed with a primary diagnosis MDD or PTSD. Primary out-
come was the nature and severity of  psychopathological symptoms assessed at base-
line using the Brief  Symptom Inventory. All outcomes were adjusted for gender and 
age. 
Results Results showed that BIF patients with a primary diagnosis MDD reported 
less severe symptoms on BSI Total and the subscales Depression, Obsession-Compulsion 
and Psychoticism than patients from Regular Mental Health Care (RMHC). There were 
no statistically significant differences in reported symptom severity on BSI Total and 
the different BSI subscales between BIF patients with PTSD and either patients from 
RMHC or patients with mild ID. Patients mild ID, did report significantly less severe 
symptoms on the subscale Depression and on the subscale Psychoticism than patients 
from RMHC. 
Discussion Since there were no other published studies into symptom profiles of  
patients with BIF compared to either patients with higher or lower levels of  cognitive 
functioning, the study was mainly exploratory in nature, providing direction for future 
research. Results indicate that symptom profiles did not widely differ, but that there 
might be some characteristics unique to patients BIF separating them as a group from 
both patients from RMHC and patients with mild ID.
Chapter 6 BSI symptom profiles of outpatients with BIF 71
Introduction
Borderline intellectual functioning (BIF) refers to the category of  intelligence on the 
normal curve of  1 to 2 standard deviations below the mean, roughly an IQ between 
70 and 85. People with BIF function in between people with normal cognitive deve-
lopment (IQ> 85) and people with an intellectual disability (IQ< 70). According to 
the normal curve of  intelligence as much as 13.6% of  the population fall into this ca-
tegory. People with BIF represent a large minority in society and in mental health care. 
BIF in itself  is not considered a disorder, nor a disability. Rather BIF is a vulnerability. 
People with BIF are more vulnerable for the development of  mental health problems 
like anxiety and depression, than people of  average or above average intelligence.1–3 
There is little to no research however on the impact of  BIF on the presentation, 
nature and severity of  mental health problems and it is unclear to what extent general 
guidelines are applicable to patients with BIF. 
In most countries, people with BIF are not in sight as a separate group in mental 
health care. BIF is often not noticed and most often not a focus of  attention. Psychi-
atric patients with BIF are diagnosed and treated in the same setting as patients with 
average or above average cognitive abilities. In theory they are treated according to the 
same guidelines. Research shows however, that psychiatric patients with BIF are more 
likely to be treated with psychotropic drugs than psychotherapy.2 
In the Netherlands, in contrast to most other countries, people with BIF are eligible 
to the same specialised mental health care services as patients with intellectual disa-
bilities (ID; IQ< 70). This offers the unique opportunity to examine, in a naturalistic 
setting, the nature and severity of  psychiatric symptoms in an otherwise largely hidden 
population. 
There are no published studies examining the differences in the nature and severity 
of  symptoms reported in mental health care by people with BIF as compared to the 
nature and severity of  symptoms reported by people with average or above average 
intelligence or people with ID. One of  the reasons is the supposed lack of  question-
naires useful in both patients with higher and lower IQs. 
Meanwhile, several studies have emphasised the importance of  self-report question-
naires in patients with low IQs, especially for the assessment of  more internalising 
psychiatric symptoms.4–7 Using self-report questionnaires is important, because when 
it comes to mood and anxiety disorders like major depressive disorder (MDD) and 
posttraumatic stress disorder (PTSD), it has been suggested that these disorders might 
present atypically in people with ID.7–10 It is unknown to what extend differences in 
presentation also occur in patients with BIF. 
The Brief  Symptom Inventory (BSI) is a self-report screener for psychopathology 
and a general outcome measure.11,12 Several studies have examined it’s use in people 
with lower IQs, including BIF and mild ID (IQ 50 -70), and found good to adequate 
psychometric properties.13–15 It is one of  the few self-report questionnaires that can be 
used both in patients with higher and lower IQs.15,16 
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The aim of  the present exploratory study was to compare, in a naturalistic outpatient 
setting, BSI symptom profiles of  patients with BIF diagnosed with two prevalent 
internalising disorders, MDD or PTSD, to patients from regular mental health care 
(RMHC) and patients with mild ID diagnosed with the same disorders. Differences 
and similarities in symptom profiles could improve our understanding of  the presenta-
tion of  MDD and PTSD in BIF, provide clues for improving diagnostics or treatment 
and further direction of  research.
Methods
Patients 
We used a sample of  adolescent and adult outpatients (aged 16 to 88) with or without 
BIF referred to either one of  the centres for RMHC or one of  the two CPID between 
2007 and 2012. The cohort consisted of  patients with a primary diagnosis MDD or 
PTSD, who were included in ROM with at least a baseline BSI. Diagnoses were the 
official diagnoses listed in the electronic patient file and classified following the Diag-
nostic and Statistical Manual of  Mental Disorders, 4th Edition, Text Revision (DSM-
IV-TR). For patients with mild ID, DSM-IV-TR diagnoses were formulated using the 
Diagnostic Manual-Intellectual Disability (DM-ID).19 The DM-ID provides guidelines 
for making accurate psychiatric diagnoses in patients with various levels of  ID and 
if  necessary offers adaptations of  DSM-IV-TR diagnostic criteria. For the diagnoses 
MDD and PTSD in mild ID, the DM-ID offers no adaptations; thus the criteria from 
DSM-IV-TR and DM-ID completely correspond. 
In the two CPID, level of  intellectual functioning was based on routine IQ testing, 
using the Dutch version of  the Wechsler Adult Intelligence Scale III (WAIS-III-
NL).20–22 Using the TIQ of  the WAIS-III-NL, following the DSM-IV-TR criteria, 
participants were either classified as BIF or mild ID and divided into 2 groups: BIF 
(TIQ 70-85) and mild ID (TIQ 50-70). There was no IQ testing in the RMHC group. 
BSI symptom profiles among the three groups were compared for MDD and PTSD. 
Routine Outcome Monitoring (ROM)
ROM is the systematic use of  questionnaires, to determine treatment effectiveness 
in everyday clinical practice in a reliable and valid way.17 The primary goal of  ROM 
is providing direct feedback on diagnoses and treatment results to both the mental 
health care professional and the patient. In addition, ROM is used for benchmarking 
procedures and research purposes. Rivierduinen (RD), a large regional mental health 
care provider in the Netherlands, uses ROM for all outpatients with a mood, anxiety 
or somatoform (MAS) disorder referred for treatment, including outpatients with BIF 
or mild ID treated in one of  the two outpatient Centres for Psychiatry and Intellectual 
Disability (CPID) (Kristal, Locations Leiden and Gouda). The Leiden ROM, as it is 
called, consists of  an extensive psychometric battery of  self-report and observer-rated 
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measures administered at intake and at follow-up, every 3-6 months. The main scree-
ner for psychopathology and general outcome measure for both the regular mental 
health care (RMHC) centres as the CPID is the Brief  Symptom Inventory (BSI).12 
In the CPID, ROM-assessments are completed in an assisted fashion.15 The assisted 
administration consists of  the following: The assessment is conducted in a one-to-one 
setting. Both the instruction and the items of  assessment instruments are either read 
together with the respondent or verbatim to the respondent. The answer feedback 
sheet contained both numerical and written representations. Kellett et al.13,18 demon-
strated that the assisted completion format does not influence respondent’s ratings 
excessively and does not affect the psychometric properties of  a test. 
Patients are informed about possible use of  anonymised data from ROM for research 
purposes. If  people object to such use, their data is removed. A comprehensive pro-
tocol safeguards anonymity of  the patients and ensures proper handling of  the data. 
The Medical Ethical Committee of  the Leiden University Medical Centre (LUMC) 
approved the regulations and agreed with this policy.17
Assessment 
Primary outcome for the present study was the nature and severity of  psychopatho-
logical symptoms assessed at baseline using the BSI.11 The BSI is a self-report (or in-
terview administered) symptom scale. It consists of  53 items, covering nine symptom 
dimensions: Somatisation (SOM), Obsession-Compulsion (O-C), Interpersonal Sensitivity (I-S), 
Depression (DEP), Anxiety (ANX), Hostility (HOS), Phobic Anxiety (PHOB), Paranoid 
ideation (PAR) and Psychoticism (PSY). Items are ranked on a Likert scale from 0 (not 
at all) to 4 (extremely). Rankings characterize the intensity of  distress during the past 
seven days. Scores can be calculated for the nine symptom dimensions and for BSI 
total.12 In ID patient populations the BSI has been shown not only to have adequate to 
excellent internal consistency and adequate validity and also to have the same 9-factor 
model.13–15
Statistical analysis
Baseline characteristics are presented as number and as a percentage (categorical 
variables) or as mean (± SD). The three patient groups were compared on gender, 
age, prevalence of  MDD and PTSD and baseline total BSI using chi-square for the 
categorical variables gender and one-way-Anova for the continuous variables age and 
baseline total BSI. BSI symptom profiles were compared using Generalised Linear 
Models, correcting for gender and age. All tests were two-tailed with p< 0.05 denoting 
statistical significance. IBM SPSS for Windows 19.0 was used for data analysis (IBM 
Corp. Armonk, NY).
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Results
Sample and demographic characteristics
From 2007-2012, 4265 patients were diagnosed with a primary diagnosis MDD or 
PTSD and included in ROM with at least a baseline BSI. Baseline sample characteris-
tics are presented in table 1. A total of  96 patients were classified with BIF (2.2%) and 
61 patients were classified as having mild ID (1.4%). In all three groups, most of  the 
participants were women, but the percentage of  women was highest in the BIF group 
(76.0%, p= 0.01) There was a significant difference among the three groups in mean 
age (p< 0.001), with the mean age of  patients in the RMHC group being eldest (40.4 
years) (p< 0.001). Therefore, all outcomes were adjusted for gender and age. 
Major Depressive Disorder (MDD)
Results of  BSI symptom profiles among RMHC, BIF and mild ID patients diagnosed 
with a primary diagnosis MDD are illustrated in figure 1. Symptom profiles did not 
differ widely, but we found notable differences in self-reported symptoms on the BSI 
among the three groups. In MDD patients there was a significant difference among 
the three groups for BSI total (overall p= 0.03, adjusted for gender and age) and the 
subscales Depression (overall p= 0.01, adjusted for gender and age), Obsession-Compulsion 
(overall p= 0.01, adjusted for gender and age) and Psychoticism (overall p< 0.001, adjus-
ted for gender and age). 
Compared to patients from RMHC, BIF patients reported less severe symptoms on 
BSI Total (BSI Total scores1.28 vs. 1.55, p= 0.01 adjusted for gender and age) and the 
subscales Depression (DEP scores 1.84 vs. 2.22, p= 0.01, adjusted for gender and age), 
Obsession-Compulsion (O-C scores 1.68 vs. 2.03, p= 0.01, adjusted for gender and age) 
and Psychoticism (PSY scores 1.19 vs. 1.60, p< 0.001, adjusted for gender and age). 
There were no statistically significant differences in symptom severity on BSI Total and 
the different BSI subscales between patients with mild ID and either patients from 
RMHC or patients with BIF.
Posttraumatic Stress Disorder (PTSD)
Figure 2 show the results of  BSI symptom profiles among RMHC, BIF and mild ID 
patients diagnosed with a primary diagnosis PTSD. Among the three groups there was 
a significant difference in PTSD patients for the subscales Depression (overall P= 0.02, 
adjusted for gender and age) and Psychoticism (overall p= 0.03, adjusted for gender and 
age). There were no statistically significant differences in reported symptom severity 
on BSI Total and the different BSI subscales between BIF patients and either patients 
from RMHC or patients with mild ID. Patients with mild ID, reported significantly 
less severe symptoms on the subscale Depression than patients from RMHC (DEP 
scores 1.49 vs. 1.93, p= 0.01, adjusted for gender and age). Also, patients with mild ID 
reported less severe symptoms on the subscale Psychoticism than patients from RMHC 
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Figure 1. BSI symptom profiles among RHMC, BIF and Mild ID patients with primary diagnosis 
depression. Outcomes adjusted for gender and age.
RMHC = Regular Mental Health Care, BIF= Borderline Intellectual Functioning, Mild ID= Mild Intellectual Disability. SOM= so-
matisation, O-C= obsession-compulsion, I-S=interpersonal sensitivity, DEP= depression, ANX= anxiety, HOS= hostility, PHOB= 
phobic anxiety, PAR= paranoid ideation and PSY= psychoticism. * denotes subscales with significant difference in scores 
among the three groups (p< 0.05)
(BSI total scores1.07 vs. 1.42, p= 0.02 adjusted for gender and age). BSI symptom 
profiles of  patients with mild ID did not differ from patients with BIF.
Figure 2. BSI symptom profiles among RHMC, BIF and Mild ID patients with primary diagnosis 
PTSD. Outcomes adjusted for gender and age.
RMHC = Regular Mental Health Care, BIF= Borderline Intellectual Functioning, Mild ID= Mild Intellectual Disability. SOM= so-
matisation, O-C= obsession-compulsion, I-S=interpersonal sensitivity, DEP= depression, ANX= anxiety, HOS= hostility, PHOB= 
phobic anxiety, PAR= paranoid ideation and PSY= psychoticism. * denotes subscales with significant difference in scores 
among the three groups (p< 0.05)
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Discussion
The present study explores, in a naturalistic setting, BSI symptom profiles of  patients 
with BIF, diagnosed with either MDD or PTSD to patients from RMHC and patients 
with mild ID diagnosed with the same disorders. Previous studies have shown the BSI 
to be a useful screener for psychopathology with adequate internal consistency and va-
lidity, including discriminant validity, in patients with both higher (IQ> 85) and lower 
IQs (IQ< 85).13,15,16 All patients in this study, whether RMHC, BIF or mild ID, scored 
well above cut-off  scores for the BSI, total and subscales, and mostly in the higher 
range compared to general ROM patient groups.23 Diagnoses were the official diagno-
ses as recorded in the registration system of  the electronic patient file. All outcomes 
were adjusted for gender and age.
Results of  the present study show that symptom profiles among patients in a natu-
ralistic setting with higher and lower IQs diagnosed with either MDD or PTSD do 
not differ widely, but there are a few notable differences. BIF patients with a primary 
diagnosis MDD reported less severe symptoms on BSI Total and the subscales Depres-
sion, Obsession-Compulsion and Psychoticism than patients from RMHC, but BSI symptom 
profiles did not differ from patients with mild ID. Comparing patients with PTSD, 
there were no statistically significant differences in BSI symptom profiles between BIF 
patients and either patients from RMHC or patients with mild ID. 
Since there are no other published studies on MDD and PTSD in BIF nor any studies 
on symptom profiles in patients with BIF compared to other patient groups, this study 
is mainly exploratory in nature. We can make some assumptions based on previous 
studies, from the field of  ID. 
Mileviciute & Hartley7 for instance, compared findings from two self-report question-
naires, Beck Depression Inventory (BDI-II)24 and Automatic Thoughts Questionnaire 
(ATQ-R),25 to that of  an informant questionnaire, the Glasgow Depression Scale 
– Caregiver Supplement (GDSC)26 in 80 individuals with mild ID of  which 30 were 
diagnosed with a depressive disorder. Unexpectedly, they found that adults with higher 
IQs in the mild ID range scored less affective depressive symptoms than adults with 
IQs in the lower range of  mild ID. The fact that in our study MDD patients with BIF 
scored lower on the subscale Depression than patients with mild ID could fit in with 
these findings. Mileviciute & Hartley7 hypothesized that mild ID adults with lower IQs 
utilise a different threshold for judging the severity of  their symptoms. If  that is the 
case however, one could wonder were the tipping point is from the lower scores of  
patients with high level mild ID and BIF, to the higher scores of  patients with MDD 
from RMHC. 
We did not find any studies aiding in the explanation of  the low scores MDD patients 
with BIF on the subscales Obsession-Compulsion and Psychoticism, although it should be 
noted that even though still adequate, the subscale Psychoticism had the lowest internal 
consistency of  al BSI subscales in patients with BIF and mild ID (Cronbach’s alpha 
0.70).15 It could be hypothesised that questions of  this subscale represent abstract 
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concepts that are difficult to understand for patients with lower IQs. However, since 
Cronbach’s alpha of  the subscales Depression (0.86) and Obsession-Compulsion (0.81) were 
considered good, this is probably not a full explanation. 
Another hypothesis could be that patients with BIF and mild ID dissimulate answers 
on questions of  the subscale Psychoticism, like “the idea that something is wrong with 
your mind”, because of  negative connotations and the tendency of  especially adults 
with BIF and higher levels of  mild ID to hide their disabilities. Both of  these hypo-
theses should be further examined. 
There were no statistically significant differences in reported symptom severity on 
BSI Total and the different BSI subscales among BIF patients and either patients from 
RMHC or patients with mild ID. PTSD Patients with mild ID, did report significant-
ly less severe symptoms on the subscale Depression and the subscale Psychoticism than 
patients from RMHC. These differences should be further examined.
The present study population reflects a naturalistic outpatient population in mental 
health care. Studies on patients with BIF in mental health care are rare, as are studies 
comparing mental health problems among patients with different levels of  cognitive 
functioning. This is the first study to compare symptom profiles of  MDD and PTSD 
patients with BIF to patients with higher and lower IQs, using the same reliable and 
valid self-report assessment instrument. Since psychiatric patients with BIF represent 
a large minority in mental health care, studying their presentation, nature and severity 
of  psychiatric symptoms is important. Results of  the present exploratory study may 
provide direction for future research. 
This study has several potential limitations. First, there was no IQ testing in the 
RMHC group. Consequently there might be individuals with unidentified BIF in 
RMHC. Considering BSI symptom profiles however, this most likely results in an un-
derestimation rather than an overestimation of  differences. Secondly, even though the 
group of  patients from RMHC was large, the groups of  patients with BIF and mild 
ID were relatively small. Further studies with bigger patient groups might make some 
of  the differences more clear. Third, the BSI is a general psychopathology screener. 
No specific MDD or PTSD self-report questionnaires were used. The simple reason 
is, at this point in time, there is no evidenced disorder-specific self-report assessment 
instrument that can reliably and validly be used in psychiatric patients with average 
or above average intelligence as well as in patients with BIF and patients with mild 
ID. Four, no informant-report questionnaires or rating scales were used. Both studies 
in RMHC and ID-specialised care have described the importance of  using multiple 
sources of  information in the assessment of  mental health.27,28 To prevent agreement 
on presence of  symptoms or distress alone, assessment instruments should preferable 
be disorder-specific.29 Future research there for should focus on comparing outco-
mes on disorder-specific self-report questionnaires in patients with BIF to those of  
informant questionnaires and rating scales like the Comprehensive Psychopathological 
Rating Scale (CPRS).30,31 Future research should focus on expanding the knowledge on 
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symptom profiles of  BIF patients by examining larger patient groups, using different 
instruments and looking at different psychiatric disorders.
Conclusions
Even though people with BIF are at high risk of  psychiatric disorders they represent 
an understudied patient group in mental health care. There is little research on the 
impact of  BIF on the presentation, nature and severity of  mental health problems and 
it is unclear to what extend general diagnostic and treatment guidelines are applicable 
to patients with BIF. Results of  the present exploratory study imply that even though 
symptom profiles of  patients with BIF and MDD or PTSD resemble those of  both 
patients with higher and lower IQs, there might also be some characteristics unique 
to patients BIF. These unique characteristics have implications for diagnostics and 
treatment and separates patients with BIF as a group from both patients from RMHC 
and patients with mild ID.
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Abstract
Introduction Mood, anxiety and somatoform (MAS) disorders are considered to 
be highly prevalent among people with borderline intellectual functioning (BIF) or 
intellectual disability (ID), but there has not been a wealth of  published research. Tre-
atment protocols of  MAS disorders in patients with BIF or ID mostly do not differ 
from general treatment protocols. In nondisabled MAS outpatients, age and cluster 
B personality traits were found to be associated with an adverse treatment outcome 
in routine clinical practice. The aim of  the present preliminary study was to explore 
whether gender, age, level of  ID and cluster B personality disorders (PD) is associated 
with treatment outcome.
Methods We used a naturalistic cohort of  93 adult outpatients referred to one of  the 
two centres for psychiatry and intellectual disabilities of  Rivierduinen (a large regional 
mental health care provider in the Netherlands) between 2007 and 2012, with a fol-
low-up of  up to 2 years. Outcome was measured using the Brief  Symptom Inventory. 
Cox regression models were used to analyse gender, age, level of  ID and cluster B PD 
as prognostic factors associated with outcome.
Results Although we found no statistically significant differences, results suggest that 
there may be an associations between treatment result and gender, age and cluster B 
PD. Hazard Ratios could be interpreted as an indication that females, young adults and 
people with a cluster B PD, may respond less favourable to treatment. Having either 
BIF or mild ID did not seem to be associated with treatment response. 
Discussion This study is a first exploration into the prognostic factors associated 
with outcome in outpatients with MAS disorders and either BIF or mild ID. Major 
limitation of  the present study is the limited sample size. Future studies are needed 
to replicate these findings in larger samples and to identify other possible associated 
factors influencing outcome in MAS disorders and in other psychiatric disorders in 
patients with BIF or ID.
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Introduction
Mood, anxiety and somatoform (MAS) disorders are considered to be highly prevalent 
among people with borderline intellectual functioning (BIF)(Total Intelligence Quo-
tient (TIQ) 70-85) or mild intellectual disability (ID) (TIQ 50 -70 and concurrent de-
ficits or impairments in present functioning).1–4 Both BIF and ID have been identified 
as risk factors for the development of  MAS disorders in both men and women.3,5–7 
According to the normalized intelligence quotient (IQ) distribution, up to 15% of  the 
population has a TIQ of  1 to 3 standard deviations (SD) below average, e.g. a TIQ of  
50 -85; BIF or mild ID. People with BIF or mild ID participate in society up to a great 
extent. For instance, they generally have work, have relationships, and in contrast to 
people with more severe ID (TIQ< 50) they have minimal care and have to fulfil high 
expectations. It is important to know how to treat MAS disorders in these patients and 
which factors are associated with treatment outcome in daily clinical practice. 
However, even though MAS disorders are prevalent in patients with BIF and ID, 
there is no wealth of  published research on the subject. There have only been a few 
clinical trials concerning the treatment of  MAS disorders in patients with ID, using 
mainly self-report questionnaires is advocated but rare and there are no studies on the 
treatment of  MAS disorders in BIF.8–10 In most countries, people with BIF are not 
considered a separate group in mental health care. BIF is not a focus of  attention and 
patients are treated according to the same guidelines as patients with average or above 
average IQs. Likewise in daily clinical practice most treatment protocols in patients 
with MAS disorders and co-morbid ID do not differ from general treatment proto-
cols.11 
We know most of  these treatments to be evidence based in nondisabled (non-ID) pa-
tients, and we know that outcome in non-ID MAS outpatients in naturalistic settings 
is associated with a number of  factors, among others whether someone is married and 
employed.12-15 In addition, a lower level of  education16 and having a co-morbid perso-
nality disorder17–21 were associated with an adverse treatment outcome. To the best of  
our knowledge there are no published naturalistic studies on prognostic factors asso-
ciated treatment outcomes in patients with either BIF or ID and MAS disorders. For 
patients with BIF or ID this means, when it comes to treating MAS disorders, there 
is a large group of  patients being treated with uncertainty about the level of  evidence 
of  most of  these treatments. And it is virtually unknown which factors predict the 
outcome of  these treatments. 
In a recent naturalistic cohort study of  892 regular mental health care (RMHC) outpa-
tients with MAS disorders and a large independent replication cohort of  1392 RMHC 
outpatients from the Leiden Routine Outcome Monitoring (ROM) study, it was found 
that older age, MAS co-morbidity, a somatoform disorder and high scores on cluster 
B personality disorder traits (affective lability, intimacy problems and self-harm) were 
independently associated with poor treatment outcome.22 
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The aim of  the present preliminary study was to explore whether some of  these 
factors were also associated with treatment outcome in a naturalistic cohort study 
of  outpatients with MAS disorders and BIF or mild ID. Following the study of  van 
Noorden et al.22 next to gender and age, we explored the association with treatment 
outcome of  cluster B personality disorder (PD). Furthermore, because both BIF and 
ID are considered to be a risk factor for the development of  MAS disorders, we ex-
plored level of  ID, BIF versus mild ID, as a prognostic factor of  treatment outcome.
Methods
Routine Outcome Monitoring 
Routine Outcome Monitoring (ROM) is a method for the systematic collection of  
relevant treatment data, using reliable and valid assessment instruments.23 The goal of  
ROM is to assess treatment effectiveness in naturalistic setting by collecting data about 
nature and severity of  psychiatric symptoms in every day clinical practise. Primarily, 
ROM is intended to provide direct feedback on diagnoses and treatment results to the 
psychiatrist and the patient. Furthermore, ROM is used for benchmarking procedures 
and research purposes. If  ROM data is used in research patient-identifiable data are 
removed from the database in order to secure patients’ confidentiality. The use of  
these anonymised data for research purposes has been approved by the Ethical Re-
view Board of  the LUMC.  
ROM is used for all outpatients referred for treatment of  a MAS disorder to Rivier-
duinen (RD), a large regional mental health care provider in the Netherlands and the 
Leiden University Medical Centre. The Leiden ROM consists of  an extensive psy-
chometric battery of  self-report and observer-rated measures administered at intake 
and at follow-up, every 3-4 months. In the two outpatient Centres for Psychiatry and 
Intellectual Disability (CPID) of  RD (Kristal, Locations Leiden and Gouda) a much 
leaner ROM test-battery is administered, at intake and follow up every 4-6 months. 
ROM consists mostly of  self-report questionnaires.
In the CPID, ROM-assessments are completed in an assisted fashion. Kellett et al.24,25 
described this “assisted completion format” using the Symptom Checklist-90 (SCL-90; 
a widely used self-report instrument evaluating a broad range of  psychological pro-
blems and symptoms of  psychopathology26 and concluded that the assisted completi-
on format was shown not to influence respondents’ ratings of  symptoms excessively 
and did not affect the psychometric properties of  the test.24,25 The assisted administra-
tion consists of  the following: The assessment is conducted in a one-to-one setting. 
Both the instruction and the items of  assessment instruments are either read together 
with the respondent or verbatim to the respondent. The answer feedback sheet con-
tains both written and numerical representations. Patients with more severe ID (e.g. 
moderate to severe ID; TIQ< 50 and concurrent deficits or impairments in present 
adaptive functioning) are as a rule not included in ROM because there is no research 
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into reliability and validity of  the self-report assessment instruments used in ROM in 
patients with more severe ID and because practical utility of  these instruments these 
patients is unknown.
Patients
We used a cohort of  adolescent and adult outpatients (aged 16 to 61) referred to one 
of  the two CPID between 2007 and 2012. The cohort consisted of  patients diagnosed 
with (a) MAS disorder(s) and either BIF or mild ID, who were included in ROM with 
at least one BSI. Flowchart of  in- en exclusion is shown in figure 1. Diagnoses were 
the official diagnoses as recorded in the registration system of  the electronic patient 
file, based on the Diagnostic and Statistical Manual of  Mental Disorders, 4th Edition, Text 
Revision (DSM-IV-TR). DSM-IV-TR diagnoses were formulated using the Diagnostic 
Manual-Intellectual Disability (DM-ID) criteria27 and based on the integrative ap-
proach of  Došen.28–30 The DM-ID provides guidelines for making accurate psychiatric 
diagnoses in patients with various levels of  IDs and where necessary offers adapta-
tions of  DSM-IV-TR diagnostic criteria. The integrative assessment considers the 
developmental perspective as a fourth dimension, in addition to the three dimensions 
of  the bio-psychosocial model. Patients were assessed multidisciplinary by at least an 
experienced psychiatrist, an experienced mental health psychologist and an experien-
ced psychiatric community worker. 
Level of  intellectual functioning was based on IQ testing, using the Wechsler Adult 
Intelligence Scale (WAIS-III-NL).31–33 Based on DSM-IV-TR criteria participants were 
divided into two groups: BIF and mild ID. Psychiatrists and mental health psycholo-
gists of  the CPID provided treatment according to Dutch evidence-based treatment 
guidelines; adapted where needed (preferably evidence-based and otherwise practi-
ce-based) to the special needs of  patients with BIF or ID. Treatment consisted mainly 
of  psychotherapy, pharmacotherapy or a combination of  both, often together with 
treatment supporting management. The goal of  this treatment supporting manage-
ment is to facilitate, among others, psycho-education, therapy adherence, generalizati-
on and crisis management. 
The predictive value of  baseline, treatment-independent patient characteristics were 
the focus of  the present analyses. Therefore management, treatment and therapist 
characteristics were not taken in to account.
Assessment of outcomes
Primary outcome for the present study was severity of  psychopathological symptoms 
assessed at baseline and follow-up using our main screener for psychopathology and 
general outcome measure the BSI.26 The BSI is essentially the brief  form of  the SCL-
90-R.34,35 It is a self-report (or interview administered) symptom scale consisting of  
53 items, covering nine symptom dimensions: Somatisation (SOM), Obsession-Compulsion 
(O-C), Interpersonal Sensitivity (I-S), Depression (DEP), Anxiety (ANX), Hostility (HOS), 
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Phobic anxiety (PHOB), Paranoid ideation (PAR) and Psychoticism (PSY). Rankings charac-
terize the intensity of  distress during the past seven days. 
Each item is ranked on a 5-point Likert scale ranging from 0 (not at all) to 4 (extreme-
ly). Scores can be calculated for the nine symptom dimensions and for 3 global indices 
of  severity of  psychopathology: The average score on all 53 items together, the num-
ber of  items with non-zero responses (or: the number of  symptoms experienced by 
the respondent) and the severity of  the existing symptoms (or: the total score divided 
by the number of  symptoms experienced by the respondent).36 Several studies sup-
port the use of  the BSI in patients with BIF and mild ID.25,37,38 The BSI has adequate 
internal to excellent internal consistency with Cronbach’s alphas ranging from the 
Dutch BIF or mild ID population from 0.70 to 0.96.38 Using normal varimax rotation 
Kellett et al.37 derived 8 interpretable factors. Confirmatory factor analysis showed 
that the underlying structure of  the BSI could be described by the same 9-factor 
structure of  the original BSI.38 Response was defined as at least 50% improvement on 
the BSI.22,39
Prognostic factors of 2-year outcome
Because of  the limited number of  patients in our cohort we could only explore a 
small number of  prognostic factors. Following the results from the naturalistic cohort 
study of  Van Noorden et al.22 in two large cohorts of  non-ID MAS outpatients and 
knowing that ID is considered a risk factor for the development of  MAS disorders, 
the prognostic factors taken into account were gender, age, level of  ID and cluster 
B PD. 
Because the transition from late adolescence into young adulthood is seen as a high-
risk developmental period in BIF and mild ID40,41, age was divided into young adults 
(age < 24), adults (age 24-40) and older adults (age > 40). Level of  ID was divided 
into borderline intellectual functioning and mild ID.42 Cluster B PD consist of  antiso-
cial PD, borderline PD, histrionic PD and narcissistic PD.42 In the analyses, presence 
of  cluster B PD was dichotomous variable.
Statistical analysis
Baseline characteristics are presented as number and percentage (categorical variables). 
or as mean (± SD) together with the interquartile range (IQR) (continuous variables). 
In- and excluded patients were compared on gender, age, level of  ID, prevalence of  
cluster B PD and baseline total BSI using chi-square for the categorical variables gen-
der and cluster B PD and independent samples t-test of  the continuous variables age 
and baseline total BSI. 
Follow-up was censored at 24 months. Because the exact point in time of  achieving 
response is unknown, the moment of  response was defined as the midpoint between 
the assessment at which response was registered and the assessment before that one. 
Associations between time to response and the predictor variables gender, age, level 
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of  ID and cluster B PD were examined with Cox proportional hazards analysis. 
Univariate hazard ratios (HR) and 95% confidence intervals (CI) for response (50% 
improvement relative to baseline scores on the BSI) were computed for baseline 
categorical and continuous predictor variables Kaplan-Meier survival curves were 
constructed for all variables. Kaplan-Meier analysis was used to calculate the percenta-
ge of  cumulative response in the total sample, the median duration of  follow-up was 
assessed using the reverse Kaplan Meier method.43 All tests were two-tailed with p < 
0.05 denoting statistical significance. IBM SPSS for Windows 19.0 was used for data 
analysis (IBM Corp. Armonk, NY ). 
Figure 1. Flowchart of inclusion and exclusion.
MAS= Mood, Anxiety and Somatoform. ROM= Routine Outcome Monitoring. BIF= borderline intellectual functioning. ID= 
intellectual disabilities. BSI= Brief Symptom Inventory
Results
Sample and demographic characteristics
From 2007-2012, 232 patients diagnosed with one of  more MAS disorders and 
BIF or mild ID, were included in ROM with at least one BSI. A total of  139 patients 
were excluded because they did not have (sufficient) follow-up assessment. A total of  
93 outpatients (40.1%) were included in the analyses. There was no difference between 
the included and excluded patients in the presence of  the different MAS disorders and 
co-morbidity (p= 0.46), the level of  ID (p= 0.16), age (p= 0.49), prevalence of  cluster 
B PD (p= 0.18) and total BSI score (p= 0.50) at baseline. There was a trend towards 
232 outpatients of one of the two centers 
for psychiatry and intellectual disability with 
MAS disorders and BIF or Mild ID from 2007 
through 2012, included in ROM with
 at least one BSI
139 (59.9%) outpatients were 
excluded:
No sufficient follow-up 
assessment (n= 139)
93 (40.1%) outpatients with MAS 
disorders and BIF or mild ID 
included in analyses  
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significance for gender (24.7% men in the included group versus 35.5% in the exclu-
ded group; χ²= 3.57, p= 0.06). 
Baseline sample characteristics, including predictor variables and DSM-IV-TR diag-
noses of  the 93 patients included in the study are presented in table 1. The majority 
of  the cohort consisted of  females (75,3%). Mean age was 32.9 (SD= 12.1). Most pa-
tients had BIF (68.8%). Mild ID was present in 31.2% of  the sample. A single anxiety 
disorder was the most common MAS disorder (54.8%). A single mood disorder was 
prevalent in 18.3% of  the sample. Single somatoform disorders were seen in 7.5% of  
the sample. MAS comorbidity was present in 19.4% of  the sample.
Table 1. Baseline characteristics of 93 outpatients diagnosed with a MAS disorders.
Categorical variables n %
   Female gender 70 75.3
   Single DSM-IV-TR Mood disorder 17 18.3
   Single DSM-IV-TR Anxiety disorder 51 54.8
   Single DSM-IV-TR Somatoform disorder 7 7.5
   MAS comorbidity 18 19.4
   Cluster B PD co-morbidity 12 12.9
   Comorbid Alcohol abuse or dependence 6 6.5
   Comorbid Drug abuse or dependence 1 1.1
BIF (TIQ 70-85) 64 68.8
Mild ID (TIQ 50-70 and concurrent deficits or 
impairments in present functioning)
29 31.2
Continuous variables Mean (SD) IQR
   Age 32.9 (12.2) 21.5-42
   BSI Total score 1.35 (0.69) 0.82-1.85
DSM-IV-TR= Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition (Text Revision). 
MAS= mood, anxiety and somatoform. PD= personality disorder. BIF= borderline intellectual functioning. 
ID= intellectual disability. TIQ= total intelligence quotient. BSI= Brief Symptom Inventory. 
SD=standard deviation. IQR= inter quartile range
Univariate prognostic factors of response
The median follow-up was 504 days (IQR = 278-730). At 2 years, 35 patients (37.6 %) 
had reached an endpoint, 15 patients (16.1%) still continued treatment. Gender, age, 
level of  ID and having a cluster B PD as predictors of  response are shown in Table 2. 
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Table 2. Univariable hazard ratios of response according to the baseline predictor variables age, 
gender and cluster B personality disorders of 93 patients with MAS disorders and borderline intel-
lectual functioning or mild to moderate intellectual disabilities.
HR’s for response over the 2-year follow-up were 1.69 (95% CI 0.83-3.46) for the 
male gender, 0.43 (95% CI 0.16-1.1) for young adults, 0.87 (95% CI 0.44-1.7) for mild 
ID and 0.21 (95% CI 0.03-1.5) for cluster B PDs. Results failed to reach statistical 
significance, indicating reliability of  findings is insufficient to meet the criterion of  p< 
0.05.44 However, the magnitude of  the differences between groups could be inter-
preted as an indication that a difference in treatment response between the groups 
for gender, age and cluster B PD might exist. Analyses should be repeated in a larger 
sample in order to gain more reliable results. Level of  ID (BIF versus mild ID) does 
not appear to be a predictor of  treatment outcome. Figure 1 shows the Kaplan-Meier 
survival curves for the predictors gender, age, level of  ID and cluster B PDs of  natu-
ralistic treatment response over the 2-year period of  follow-up.
Predictor variables 
(categorical and continuous)
HR (95% CI) p-value
Gender
             Female 1.00
             Male 1.69 (0.83-3.46) 0.15
Age
            > 39 years                   1.00
            24-39 0.99 (0.5-2.0) 0.98
            < 24 years 0.43 (0.16-1.1) 0.08
Level of ID
             BIF 1.00
             Mild ID 0.87 (0.44-1.7) 0.99
Cluster B PD 0.21 (0.03-1.5) 0.12
MAS= mood, anxiety and somatoform. HR= Hazard Ratio. CI= confidence interval. BIF= borderline 
intellectual functioning. ID= intellectual disability. PD= personality disorder. Response was defined as 
≥ 50% reduction on the Brief Symptom Inventory
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Figure 2. Kaplan Meier curves for response according to the baseline predictor variables age, gen-
der and cluster B personality disorders of 93 patients with MAS disorders and borderline intellectu-
al functioning or mild intellectual disabilities.
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Continuation Figure 2. 
PDB= cluster B personality disorders. BIF= borderline intellectual functioning. 
ID= intellectual disabilities
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Discussion 
This study is a first exploration into the prognostic factors associated with outcome in 
outpatients with MAS disorders and either BIF or (mild) ID. The results suggest that 
there may be an associations between treatment result and gender, age and cluster B 
PD. The confidence intervals of  our results were wide and included 1, but HRs could 
be interpreted as an indication that females, young adults and people with a cluster B 
PD, may respond less favourable to treatment. Level of  ID did not play a role. 
In the Leiden Routine Outcome Monitoring Study, Van Noorden et al.22 found no 
difference in treatment effect between males and females in a naturalistic psychiatric 
outpatient setting of  non-ID MAS disorder patients. Older age and several cluster B 
PD traits (affective lability, intimacy problems and self-harm) were associated with 
poor outcome. However, their study did not include patients with BIF or mild ID. 
To our knowledge, this study is the first study on prognostic factors associated with 
treatment outcome in outpatients with MAS disorders and co-morbid BIF or mild 
ID. Strengths of  this study lie in the well-defined patient group with MAS disorders 
and the carefully applied label of  BIF and mild ID using extensive IQ testing. Ano-
ther strength is the use of  ROM and the use of  a proven reliable en valid self-report 
questionnaire, the BSI. 
 Apart from the relatively small sample size, which limited the numbers of  prognostic 
factors that could be explored, this study had several potential limitations. The design 
may be subject to selection bias. The CPID of  RD treat patients with all levels of  
intellectual disability, but patients with more severe ID (e.g. moderate to severe ID) 
are mostly not included in ROM. Also, because ROM had a working-up phase there 
was a loss in follow-up during the first years after the start of  data collection. Referral 
pathways are well established and there is a focus on patients with BIF as a separate 
group. Referral of  patients with BIF and psychiatric disorders to specialized mental 
health care is the default procedure. Even so there might be patients with (unknown) 
higher IQs in the BIF range in regular mental health care. This means that patients 
included in ROM might differ from patients not included in ROM. Second, as in other 
naturalistic studies involving ROM22,39, attrition is high and even though we know that 
this is at least in part due to absence of  follow-up in the ROM implementation phase, 
we do not know the reasons for loss to follow-up in later stages during the study. 
Third, treatment consisted of  either psychotherapy, pharmacotherapy or a combinati-
on of  both, following existing guidelines from regular psychiatry and our own adapted 
care programs, but we did not include information on the specific types of  treatment. 
Fourth, the BSI may not be specific enough to fully capture clinical changes in all 
MAS disorders. Even though they were not very prevalent, this might especially hold 
true for somatoform disorders.44 Finally, due to the design of  the study exact point of  
response could not be inferred and patients who did not reach the response criteria 
in 2 years were labelled as non-responders. Also possible relapse after initial response 
was not taken into account. 
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In summary, this study is a first exploration into the prognostic factors associated with 
outcome in outpatients with MAS disorders and either BIF or mild ID. Even though 
CI’s were wide and all included 1, HR’s seem could be interpreted to indicate that 
being female, being a young adult and having a cluster B PD is associated with decre-
ased chances of  treatment response. Having either BIF or mild ID does not seem to 
be associated with treatment response. Since in our CPID the same essential treatment 
protocols are used but adapted to level of  cognitive functioning, this might mean that 
when patients are treated according to their cognitive abilities, it does not matter for 
treatment outcome whether they have BIF or mild ID. 
Future studies are needed to replicate these findings in larger sample sizes and to 
identify other possible associated factors influencing outcome in MAS disorders and 
in other psychiatric disorders in patients with BIF or an ID. In the absence of  fu-
rther data, the results suggest that practitioners should be aware that patients with the 
characteristics mentioned above need extra attention.
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Summary and main findings
The aim of  this thesis was to explore prevalence of  psychiatric disorders and nature 
and severity of  psychiatric symptoms of  outpatients with borderline intellectual func-
tioning (BIF) in mental health care.  
Chapter 2 provides an overview of  the concept of  BIF and its place in past en 
present DSMs and other classification systems like ICD. In the history of  the DSM, 
BIF had different names and different boundaries and the classification BIF travelled 
through earlier DSMs until it literally ended in last place in DSM-5. IQ test scores, the 
last criterion left in the classification of  BIF in the DSM-IV, are removed from the 
diagnostic description in DSM-5, leaving the concept without a clear definition. 
 In our overview we describe the importance of  a well-defined classification and rene-
wed regard to the concept of  BIF. People with BIF, or an IQ between 70 and 85, are 
a vulnerable group both in society and in mental health care. At the same time, they 
present a largely hidden patient population. People with BIF are rarely identified in 
general mental health care and almost invisible in research.
Chapter 3 describes the results of  a cross-sectional anonymized medical chart review 
among patients from the Dutch regional mental health care provider Rivierduinen. 
The aim of  the study was to explore the rates of  different axis I psychiatric disorders 
in outpatients with BIF, in order to learn more about psychiatric morbidity of  patients 
with BIF in comparison to patients from regular mental health care (RMHC) (i.e. not 
selected on IQ), and patients with mild intellectual disabilities (ID). 
Official DSM-IV-TR axis I diagnoses as they were registered in the electronic patient 
file were compared among 235 patients with BIF, 152 patients with mild ID and 1026 
patients from RMHC. All three groups consisted of  outpatients registered on January 
1st 2011. 
Results show that depressive and psychotic disorders were less common classifications 
in psychiatric outpatients with BIF compared to outpatients from RMHC. PTSD and 
V-codes were more common. Compared to outpatients with mild ID, psychotic disor-
ders were significantly less common.  
In chapter 4 the rates of  all DSM-IV-TR axis II diagnoses of  personality disorder 
(PDs) were compared among the same 235 outpatients with BIF, 152 outpatients with 
mild ID and 1026 outpatients from regular mental health care.
We found that the rate of  PD diagnoses in outpatients with BIF in daily clinical 
practice was very high (52.8%) compared to both outpatients from RMHC (19,3%) 
and outpatients with mild ID (33.6%). PD not otherwise specified (NOS) and bor-
derline PD were the most frequently diagnosed PDs in outpatients with BIF. In all 
three groups the vast majority of  outpatients diagnosed with a PD had one ore more 
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co-morbid axis I disorder. Mood, Anxiety and Somatoform (MAS) disorders were the 
most prevalent axis I disorders in all three groups. 
Chapter 5 presents the results of  a study into the utility of  the Brief  Symptom 
Inventory (BSI) in psychiatric outpatients with BIF or mild ID. The BSI is a widely 
used standardised self-report questionnaire in general psychiatry. It can be used across 
a wide range of  symptoms and diagnoses and can be applied across different thera-
peutic interventions. It is one of  the primary screeners and general psychopathology 
outcome measures of  ROM in regular mental health care. 
All participants in this study were new patients of  the two CPID of  the regional men-
tal health care provider Rivierduinen between April 1st 2008 and October 1st 2009. In 
total, 224 psychiatric outpatients with either BIF or mild ID participated. The BSI was 
used in an assisted fashion and for part of  the sample (n = 43) a list of  ‘difficult items’ 
was kept. The assisted fashion meant that participants were always aided by a mental 
health care professional, were needed, in completing the self-report questionnaire. A 
question was considered difficult when it was not completely or properly understood. 
Internal consistencies were good to adequate, ranging from 0.70 – 0.96. Subscale in-
tercorrelations showed differentiation between the subscales. Discriminant validity was 
shown for the subscales Depression, Anxiety and Phobic Anxiety. Confirmatory factor 
analysis showed that the underlying structure of  the BSI could be described by the 
same 9-factor model as reported in previous studies. It was concluded that the BSI is a 
useful screener and general outcome measure for psychopathology in people with BIF 
or mild ID.
There is little available research on the impact of  BIF on presentation, nature and 
severity of  co-morbid psychiatric disorders. Therefore, the aim of  the study described 
in chapter 6 was to explore, in a naturalistic outpatient setting, BSI symptom profiles 
of  patients with BIF diagnosed with a primary diagnosis of  either major depressive 
disorder (MDD) or posttraumatic stress disorder (PTSD) to patients from RMHC and 
patients with mild ID diagnosed with the same disorders. We used a cohort of  outpa-
tients (aged 16 to 88) referred to either one of  the centres for RMHC or one of  the 
two CPID between 2007 and 2012. The sample consisted of  patients with a primary 
diagnosis MDD or PTSD, who were included in ROM with at least a baseline BSI. All 
outcomes were adjusted for gender and age. Results showed that compared to patients 
from RMHC, BIF patients with a primary diagnosis MDD reported less severe symp-
toms on BSI Total and the subscales Depression, Obsession-Compulsion and Psychoticism. 
There were no statistically significant differences in reported symptom severity on BSI 
Total and the different BSI subscales between BIF patients with PTSD and either pa-
tients from RMHC or patients with Mild ID. Patients Mild ID, did report significantly 
less severe symptoms on the subscale Depression and on the subscale Psychoticism than 
patients from RMHC. 
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Since there were no other published studies into symptom profiles in patients with 
BIF compared to either patients with higher or lower levels of  cognitive functioning, 
the study was mainly exploratory in nature. 
Last, chapter 7 offers the results of  a preliminary study exploring the association bet-
ween gender, age, level of  ID and cluster B PD to treatment outcome in outpatients 
with mood, anxiety and somatoform (MAS) disorders. We used a naturalistic cohort 
of  93 adult outpatients referred to one of  the two CPID of  Rivierduinen between 
2007 and 2012, with a follow-up of  up to 2 years. Outcome was measured using the 
BSI. Gender, age, level of  ID and cluster B PD were analysed as prognostic factors of  
outcome using Cox regression. Although confidence intervals were wide and inclu-
ded 1, based on hazard ratios (HRs) the results suggest that there may be associations 
between treatment result and gender, age and cluster B PD. Hazard Ratios could be 
interpreted as an indication that females, young adults and people with a cluster B PD, 
may respond less favourable to treatment. Having either BIF or mild ID did not seem 
to be associated with treatment response. Future studies in larger samples are needed 
to replicate these findings and identify other possible associated factors influencing 
treatment outcome.  
General discussion 
In mental health care, up until now, there has not been much regard for BIF. In 
research BIF is almost invisible. This is striking, since BIF actually represents a large 
minority in both society and mental health care. This thesis examines psychiatric di-
sorders and the nature and severity of  psychiatric symptoms of  outpatients with BIF 
in mental health care for the first time. Also novel is the comparison of  outpatients 
with BIF to both patients from RMHC and patients with mild ID. Being able to iden-
tify and compare these different patient groups is important because of  the possible 
implications for specific attention and/or adaptation of  diagnostic and treatment 
programs. 
In this thesis we showed that patients with BIF in secondary outpatient mental health 
care have a different mix of  psychiatric disorders than patients in regular mental 
health care and patients with mild ID. This is important knowledge in the organisation 
of  mental health care for this patient group. A high percentage of  patients with PTSD 
implies a need for well trained EMDR therapists, coached in using these techniques in 
patients with low IQs. A high rate of  PD signifies a need for adapted therapies. Cur-
rently used therapies in general mental health care, like Dialectical Behaviour Therapy 
(DBT)e.g.1 and Mentalisation Based Therapy (MBT)e.g.2,3 are heavily cognitively based 
and require a level of  abstraction that is too difficult for most people with low IQs. 
For patients with BIF, treatment needs to be more concrete with smaller treatment 
steps, containing more repetitions and with more attention to generalisation. The two 
CPID have adapted programs for stabilisation and EMDR. For BIF patients with PD 
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a customised emotion regulation treatment and skills training was developed.4
An important outcome of  this thesis is the feasibility of  the BSI in patients with BIF 
and mild ID. For one, routine outcome monitoring (ROM) has become an important 
part of  mental health care. The use of  ROM in patients with low IQs (TIQ< 85) 
however was lagging behind because there has been a lack of  psychometrically tested 
self-report questionnaires. Self-report questionnaires are an important part of  ROM. 
They are also important for patients with BIF and mild ID, especially for mapping 
more internalising psychopathology. Demonstrating the utility of  the BSI contributed 
to the development of  ROM for patients with low IQs. Meanwhile ROM has become 
an important part of  specialised mental health care throughout the Netherlands and 
the BSI has become an important screener and outcome measure in several specialised 
mental health care facilities.
Secondly, by using the same questionnaires in both people with higher and lower 
IQs, it allows for examining similarities and differences in nature and severity of  
symptoms, treatment effect and for instance efficacy of  different treatments among 
patients functioning at different cognitive levels in daily clinical practice. In this thesis 
we explored some of  these possibilities by comparing BSI symptom profiles among 
patients with BIF, patients from RMHC and patients with mild ID, diagnosed with 
either MDD or PTSD. We also explored possible predictors associated with treatment 
outcome in patients with lower IQs. Results so far show that patients with BIF do not 
differ widely from either patients in RMHC or patients with mild ID, but there might 
be some aspects unique to patients with BIF that need to be further investigated and 
might have clinical implications. 
Strong point of  this thesis is the fact that all IQs of  patients in the two CPID were 
assessed using a standardised IQ test.5–7 Therefore the label of  either BIF or mild ID 
was always carefully applied. The classification of  BIF, used in this thesis, is the classi-
fication of  the V-code BIF as it is formulated in the Diagnostic and Statistical Manual 
of  Mental Disorders, revised 4th edition (DSM-IV-TR). In daily clinical practise next 
to IQ level, in the CPID the developmental perspective is always taken into account, 
including social and emotional development and level of  adaptive functioning in inter-
preting psychiatric symptoms and classifying psychiatric disorders.8–11 
Major limitation in the present study is the limited visibility of  BIF in mental health 
care. Even though Rivierduinen has two special CPID, and referral pathways are 
well-established, referral still depends on recognition. It is unknown how many indi-
viduals with unidentified BIF are treated in regular psychiatric services and to what 
extent and with respect to which characteristics the group referred to the CPID is a 
selection. Based on prevalence of  BIF in the general population and increased risk of  
for the development of  mental health problems prevalence of  BIF in mental health 
care is probably higher than generally assumed. Furthermore, results in this thesis 
come from studies done in secondary specialised mental health care; results cannot 
evidently be generalized to other patient groups or the general population. 
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Another limitation is the fact that, although they were made multidisciplinary and 
integrative, psychiatric diagnoses were mostly clinical diagnoses and not based on a 
structured interview. The reason can be found in the lack of  existing valid and reliable 
assessment instruments for people with BIF. The Mini International Neuropsychiatric 
Interview (MINI)12, used to establish psychiatric diagnoses in ROM in general mental 
health care, does not fit in with the cognitive abilities of  people with low IQs. Ques-
tions in the MINI are made up of  long compound sentences. Also the MINI relies 
heavily on memory and the ability to estimate timelines. All demands that are quite 
difficult to meet for most people with low IQs. Psycho-diagnostic instruments deve-
loped for people with ID, were not readily available.13 As yet, there is no psycho-diag-
nostic instrument available that can be used in both people with higher and lower IQs. 
The size of  the study population unfortunately was limited. The two CPID are small 
and treat a vast variety in clinical diagnoses. Establishing a sufficiently homogeneous 
research population proved to be difficult. Also, time and funds were limited during 
the course of  this thesis. Cutbacks in mental health care shifted focus to the primary 
process of  treatment, leaving little time and resources for care development and re-
search. Last, because of  largely absent previous research, studies in the present thesis 
were largely exploratory in nature. 
General conclusions and recommendations for further research
Results from the studies in this thesis show that it is possible to focus on BIF as a se-
parate group in mental health care. Focusing on BIF in mental health care is important 
because people with BIF represent a large minority that up until now has not been 
well addressed. 
According to the Dutch Social Cultural Research Institute14 about 2.2 million peo-
ple in the Netherlands have an IQ between 70 and 85. In their report “Care better 
understood”,14 the Dutch Social Cultural Research Institute concludes that care needs 
of  people with BIF have increased six fold between 1998 and 2011.14 Social develop-
ments like reduced availability of  simple work, higher demands in education and in-
creasing digitisation are main explanations for this growth in care needs. Nonetheless, 
despite or maybe because of  increasing care demands, the Dutch government decided 
to become more reticent in the delivery of  specialised care to people with BIF. This 
limits possibilities of  preventive care increasing the risk of  not only psychosocial and 
health problems but especially the development of  psychiatric disorders. 
Often patients with BIF present in mental health care with a combination of  pro-
blems in cognitive, social-emotional and adaptive function, multiple complex psychia-
tric disorders and a mix of  psychosocial problems. In order to adequately address this 
complex interaction of  BIF, psychiatric disorders and psychosocial problems, active 
detection of  BIF in mental health care is essential. Professionals should be trained in 
recognizing BIF and in the extra communication and practical skills needed to diagno-
se and treat psychiatric disorders in patients with BIF.e.g.15
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To develop affordable stepped care that fits in with the possibilities and limitations of  
psychiatric patients with BIF, future research should focus on diagnostics of  psychi-
atric disorders in patients with BIF and investigate treatment programs on utility and 
effectiveness of  care tailor-made for the large minority of  mental health care patients 
that have gone unnoticed for far too long.
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Zwakbegaafdheid
Dit proefschrift gaat over psychiatrische stoornissen bij mensen met zwakbegaafdheid. 
Met zwakbegaafdheid bedoelen we een niveau van intellectueel functioneren dat lager 
is dan bij ‘normale’ of  gemiddelde intelligentie en hoger dan bij een verstandelijke 
beperking. Dat is het beste uit te leggen met behulp van de normaalverdeling van 
intelligentie (zie figuur 1). Een verstandelijke beperking wordt gedefinieerd als een 
intelligentie quotiënt (IQ) van 2 of  meer standaard deviaties (SD) onder het gemid-
delde van 100 op de normaalverdeling. Zwakbegaafdheid wordt gedefinieerd als een 
IQ tussen 1 en 2 SD onder het gemiddelde. Grofweg komt dit overeen met een IQ op 
een gestandaardiseerde IQ test tussen 70-85. Volgens de normaalverdeling valt 13,59% 
van de bevolking in deze categorie; ofwel meer dan 2 miljoen Nederlanders.
Figuur 1. Normaalverdeling van intelligentie in de algemene bevolking. Intelligentie quotiënt (IQ) 
is een score zoals die behaald wordt op een gestandaardiseerde test ontworpen om menselijke 
intelligentie te meten. De mediane ruwe score van de normatieve steekproef wordt gedefinieerd 
als een IQ van 100. Elke standaarddeviatie (SD) naar boven of beneden staat gelijk aan 15 IQ pun-
ten. Door deze definitie scoort ongeveer tweederde van de bevolking een TIQ tussen 85 en 115. 
Zwakbegaafdheid wordt gedefinieerd als een IQ tussen 1 en 2 SD onder het gemiddelde (IQ 70-85) 
en verstandelijke beperking wordt gedefinieerd als een IQ van 2 SD of meer onder de gemiddelde 
(IQ< 70).
Zwakbegaafde mensen vallen niet op in de maatschappij. Ze zijn niet makkelijk te her-
kennen aan bepaalde uiterlijke kenmerken, persoonlijkheidstrekken of  gedrag. Ze pro-
beren over het algemeen juist angstvallig om hun beperking te verbergen en ‘normaal’ 
te zijn. En dit lukt hen over het algemeen heel goed. Als mensen hun zwakbegaafd-
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heid goed weten te verbergen helpt dit hen om zich te handhaven in de maatschappij. 
Maar de keerzijde is dat deze mensen altijd op hun tenen moeten lopen. Dit maakt 
hen kwetsbaar en verhoogt het risico op het ontstaan van psychische problemen en 
psychiatrische stoornissen. Dat dit zo is, is ook aangetoond in onderzoek. Toch lijkt 
het er op dat zwakbegaafde mensen minder vaak behandeld worden voor hun psychi-
sche problemen. En als ze al behandeld worden krijgen ze vaker medicatie en minder 
vaak psychotherapie. Daar komt bij dat ze vaak te hoog ingeschat worden. Ze krijgen 
dan een uitleg over ziekte en behandeling die voor hen te ingewikkeld is. 
In dit proefschrift wordt onderzoek beschreven naar de aard en ernst van psychische 
symptomen en psychiatrische stoornissen bij mensen met zwakbegaafdheid die in 
verband met ernstige psychische klachten verwezen werden naar een gespecialiseerd 
centrum waar zwakbegaafdheid een specifiek aandachtspunt is.
Zwakbegaafdheid als diagnostische categorie
Zo eenvoudig als we net zwakbegaafdheid hebben uitgelegd is de diagnostiek ervan 
helaas niet. Zwakbegaafdheid is natuurlijk veel meer dan alleen een ‘slechte score’ op 
een IQ test. Maar om precies uit te leggen wat zwakbegaafdheid dan wel inhoudt, is 
ook moeilijk. Zwakbegaafdheid is altijd een ingewikkeld begrip geweest. In de ver-
schillende edities van de Diagnostic and Statistical Manual of  mental disorders (DSM), het 
meest gebruikte classificatiesysteem voor psychiatrische aandoeningen, heeft de classi-
ficatie zwakbegaafdheid in één of  andere vorm altijd een plek gehad. Maar de classifi-
catie heeft onder verschillende namen en op verschillende plekken in de DSM gestaan. 
Zo was zwakbegaafdheid, toen lichte mentale retardatie genoemd, in de eerste edities 
van de DSM de lichtste vorm van wat we nu een verstandelijke beperking noemen. 
Het was dus een stoornis. Vanaf  de derde editie van de DSM, DSM III, werd zwak-
begaafdheid niet langer gezien als het hoogste niveau van wat ze toen zwakzinnigheid 
noemden. Deze plek werd nu ingenomen door lichte zwakzinnigheid (IQ 50-70). Later 
is dit lichte verstandelijke beperking gaan heten. Zwakbegaafdheid werd vanaf  die tijd 
een zogenoemde V-code. V-codes worden gebruikt voor andere problemen of  aan-
doeningen die in verband staan met een in de DSM beschreven psychische stoornis. 
Dat zwakbegaafdheid een V-code werd, betekende dat het niet langer beschouwd werd 
als stoornis. Immers, V-codes worden in de DSM gedefinieerd als ‘bijkomende pro-
blemen die een reden voor zorg kunnen zijn’. Het gaat dus niet om stoornissen. Daar 
komt bij dat de IQ-grenzen (en dus de criteria) van de classificatie meerdere malen 
zijn aangepast. Wat het extra lastig maakt is dat er in de nieuwste versie van de DSM, 
de DSM-5, helemaal geen IQ grenzen meer gegeven worden voor zwakbegaafdheid. 
Daarmee is het nòg moeilijker geworden om zwakbegaafdheid goed te classificeren. 
Nu zwakbegaafdheid niet meer in het lijstje voorkomt met de niveaus van ernst van 
verstandelijke beperking en zelfs geen duidelijke criteria meer heeft, lijkt het wel alsof  
de classificatiesystemen van psychische stoornissen samenzweren met zwakbegaafde 
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mensen om hun psychische problemen te verbergen. Daarom is het niet verwonderlijk 
dat er weinig aandacht is voor zwakbegaafdheid als bijkomende diagnose bij andere 
psychiatrische stoornissen.
Specialistische zorg voor zwakbegaafde psychiatrische patiënten
In de meeste landen worden zwakbegaafde mensen in de geestelijke gezondheidszorg 
(GGZ) niet als aparte groep gezien. Ze worden behandeld in de ‘reguliere’ GGZ. 
Bijzonder in Nederland is het feit dat mensen met een IQ tussen 70 en 85, zwakbe-
gaafdheid, wél in aanmerking komen voor behandeling in gespecialiseerde centra voor 
psychiatrie en verstandelijke beperking. 
Helaas wordt zwakbegaafdheid dan vaak niet expliciet benoemd maar worden de 
zwakbegaafde patiënten samengevoegd met patiënten met een lichte verstandelijke 
beperking tot één groep met de naam Licht Verstandelijk Gehandicapten (LVG), of  
-tegenwoordig- Lichte Verstandelijke Beperking (LVB). Hiermee wordt dus een gro-
tere groep mensen bedoeld dan de mensen volgens de classificatie van de DSM een 
lichte verstandelijke beperking hebben. 
Rivierduinen, een grote regionale GGZ aanbieder in de Randstad, heeft een gespeci-
aliseerd centrum voor mensen met psychiatrische stoornissen en een verstandelijke be-
perking met de naam Kristal Centrum Psychiatrie en Verstandelijke Beperking. Kristal 
heeft twee locaties; één in Leiden en één in Gouda. Kristal biedt integratieve multidis-
ciplinaire diagnostiek en behandeling voor psychiatrische patiënten met een 
IQ< 85. Bij Kristal wordt gewerkt vanuit het ontwikkelingsperspectief. Dit betekent 
dat er in de diagnostiek en behandeling van psychiatrische stoornissen niet alleen 
rekening wordt gehouden met het IQ, maar ook met de sociale en emotionele ontwik-
keling en het niveau van adaptief  functioneren. Omdat de in verstandelijke beperking 
gespecialiseerde centra van Rivierduinen bij alle patiënten een IQ bekend is, kunnen 
we bij deze gespecialiseerde centra wél onderscheid maken tussen zwakbegaafdheid en 
een lichte verstandelijke beperking.
Gedurende de 10 jaar van haar bestaan heeft Kristal veel klinische ervaring opge-
bouwd met het diagnosticeren en behandelen van psychiatrische stoornissen bij 
patiënten met een laag IQ. Het diagnostisch proces en de behandeling van Kristal zijn 
aangepast aan de cognitieve, sociaal-emotionele en adaptieve vaardigheden van patiën-
ten met een IQ onder de 85 en beschreven in een eigen zorgprogramma “Psychiatrie 
en Verstandelijke Beperking”. 
Routine Outcome Monitoring
Binnen de geestelijke gezondheidszorg willen wij graag het effect van de behandeling 
volgen. Om die reden worden voor, tijdens en na de behandeling de klachten en pro-
blemen van de patiënt gemeten met behulp van vragenlijsten. Het herhaald meten van 
klachten en problemen wordt Routine Outcome Monitoring (ROM) genoemd. 
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De resultaten van deze ROM-metingen worden door de behandelaar met de pati-
ent besproken. Door het vergelijken van resultaten op verschillende meetmomenten 
kunnen patiënten zien welke klachten en problemen verbeteren en welke niet. Indien 
nodig kan de behandeling worden aangepast. 
De resultaten van de metingen worden ook gebruikt voor wetenschappelijk onder-
zoek. Dit gebeurt anoniem. Patiënten weten dit en kunnen hier bezwaar tegen maken: 
als mensen niet willen dat hun ROM-gegevens voor onderzoek gebruikt worden, dan 
worden deze gegevens verwijderd. 
Ook bij Kristal Centrum Psychiatrie en Verstandelijke Beperking wordt gebruik ge-
maakt van ROM. Toen we hier in 2009 een start mee maakten was het afnemen van 
vragenlijsten, met name zelfrapportage vragenlijsten, bij mensen met een lager IQ iets 
heel nieuws. Inmiddels wordt er in bijna alle centra gespecialiseerd in psychiatrie en 
verstandelijke beperking gebruik gemaakt van ROM.  
Omdat we graag patiënten met hogere en lagere IQs met elkaar willen kunnen verge-
lijken, maken we zoveel mogelijk gebruik van dezelfde vragenlijsten als in de ‘reguliere’ 
psychiatrie, oftewel de regionale centra van Rivierduinen. Of  dit mogelijk was, moes-
ten we natuurlijk wel eerst bekijken. Een belangrijke stap in dit proefschrift was daar-
om het onderzoeken van de bruikbaarheid van de Brief  Symptom Inventory (BSI), 
een veel gebruikte zelfrapportage vragenlijst in de ‘reguliere’ psychiatrie, bij mensen 
met een lager IQ. 
Om ROM goed te kunnen gebruiken bij Kristal hebben we de werkwijze wel iets 
moeten aanpassen.
We vragen niet zomaar aan mensen om zelfstandig vragenlijsten in te vullen. Hun 
behandelaren helpen ze daar bij. We noemen deze werkwijze het ‘assisted completion 
format’. De behandelaar kan instructies of  vragen samen lezen of  voorlezen en even-
tueel de taal van sommige vragen aanpassen als deze voor de patiënt te moeilijk blijkt 
te zijn. 
Doelstelling 
Het algemene doel van dit proefschrift was om meer zicht te krijgen op de aard en de 
ernst van de psychiatrische symptomen en psychiatrische stoornissen van poliklinische 
patiënten gediagnosticeerd met zwakbegaafdheid en onder behandeling in de tweede-
lijns GGZ. We gebruikten hiervoor geanonimiseerde diagnostische informatie uit het 
officiële registratiesysteem van het elektronisch patiëntendossier, onderzochten het nut 
en de psychometrische eigenschappen van de BSI en gebruikten vervolgens ROM-ge-
gevens van patiënten uit de ‘reguliere’ GGZ en patiënten met zwakbegaafdheid of  een 
lichte verstandelijke beperking om te kijken naar symptoomprofielen en voorspellende 
factoren voor behandeling.
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Belangrijkste bevindingen
In hoofdstuk 1 van dit proefschrift worden, net als in deze samenvatting, de theore-
tische achtergronden en de klinische praktijk beschreven. In hoofdstuk 2 wordt een 
overzicht gegeven van het begrip zwakbegaafdheid. Wat is de betekenis van de classi-
ficatie zwakbegaafdheid en op welke plekken kun je zwakbegaafdheid terugvinden in 
internationale classificatiesystemen voor psychiatrische stoornissen zoals de DSM? We 
beschrijven hoe zwakbegaafdheid in de loop van de tijd beetje bij beetje een ande-
re betekenis kreeg en hoe de classificatie door de verschillende edities van de DSM 
‘reisde’ om uiteindelijk in de nieuwste editie letterlijk als laatste classificatie te eindigen. 
En zonder duidelijke definitie. Immers het laatste criterium voor het vaststellen van 
zwakbegaafdheid, een IQ tussen 70 en 85, wordt niet meer genoemd in de DSM-5.
In ons overzicht beschrijven we het belang van een goed gedefinieerde classificatie 
en hernieuwde aandacht voor zwakbegaafdheid. Zwakbegaafde mensen vormen een 
kwetsbare groep in de maatschappij én in de geestelijke gezondheidszorg. Tegelijker-
tijd blijven ze in de zorg op dit moment een grotendeels verborgen. Zwakbegaafdheid 
wordt zelden herkend in de geestelijke gezondheidszorg en is grotendeels onzichtbaar 
in onderzoek.
In hoofdstuk 3 beschrijven we de resultaten van een onderzoek naar het voorkomen 
van verschillende psychiatrische stoornissen bij zwakbegaafde poliklinische patiënten 
onder behandeling bij Kristal Centrum Psychiatrie en Verstandelijke Beperking. Op 
die manier wilden we meer te weten komen over welke psychiatrische stoornissen veel 
voorkomen bij zwakbegaafde patiënten en of  dit anders is dan bij patiënten met een 
hoger of  een lager IQ. We vergeleken de officiële psychiatrische diagnoses, uit het 
elektronische patiëntendossier van drie groepen patiënten: zwakbegaafde patiënten, 
patiënten met een lichte verstandelijke beperking en patiënten onder behandeling in 
de ‘reguliere’ psychiatrie. In het onderzoek zaten 235 zwakbegaafde patiënten, 152 
patiënten met een lichte verstandelijke beperking en 1026 patiënten uit de ‘reguliere’ 
psychiatrie ofwel de regionale centra van Rivierduinen. 
Depressieve stoornissen en psychotische stoornissen bleken minder vaak gediagnosti-
seerd te worden bij zwakbegaafde patiënten in vergelijking met patiënten in de ‘regu-
liere’ tweedelijns psychiatrische zorg. Posttraumatische stressstoornissen en V-codes 
kwamen, in vergelijking met patiënten in ‘reguliere’ tweedelijnszorg, vaker voor. In 
vergelijking met patiënten met een lichte verstandelijke beperking kwamen psychoti-
sche stoornissen minder vaak voor.
In hoofdstuk 4 bestudeerden we, bij dezelfde drie groepen patiënten, het voorko-
men van persoonlijkheidsstoornissen. We ontdekten dat zwakbegaafde patiënten heel 
vaak gediagnosticeerd waren met een persoonlijkheidsstoornis (52,8%). Veel vaker 
dan patiënten in de ‘reguliere’ zorg (19,3%) en ook vaker dan patiënten met een lichte 
verstandelijke beperking (33,6%). De persoonlijkheidsstoornis ‘niet anderszins om-
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schreven’ en de borderline persoonlijkheidsstoornis kwamen het vaakst voor. Voor alle 
drie de groepen gold dat de mensen die gediagnosticeerd waren met een persoonlijk-
heidsstoornis in het merendeel van de gevallen ook een andere psychiatrische stoornis 
hadden, meestal een stemmingsstoornis of  een angststoornis. 
Hoofdstuk 5 beschrijft de resultaten van een studie naar de toepasbaarheid van een 
veel gebruikte vragenlijst in de psychiatrie, de Brief  Symptom Inventory (BSI), bij 
mensen met een lager IQ. De BSI is een zelfrapportage vragenlijst die in de geestelijke 
gezondheidszorg veel gebruikt wordt om psychische klachten in kaart te brengen en 
om bijvoorbeeld het effect van behandelingen te meten. Het voordeel van de BSI is 
dat je er veel verschillende symptomen mee in kaart kunt brengen en dat hij dus bruik-
baar is bij een grote verscheidenheid aan psychiatrische stoornissen. De BSI heeft een 
totale score maar ook een aantal subschalen waarvoor je apart scores kunt berekenen. 
Zo heeft de BSI een subschaal Depressie, een subschaal Angst, een subschaal Cognitieve 
problemen en nog een paar subschalen. Het is één van de meest gebruikte vragenlijsten 
in de ROM. 
In totaal werd de BSI afgenomen bij 224 patiënten met ofwel zwakbegaafdheid of  een 
lichte verstandelijke beperking. De vragenlijst werd altijd samen met de patiënt inge-
vuld en voor een deel van de patiënten hielden we precies bij welke vragen ze moeilijk 
vonden. Mensen mochten zelf  aangeven welke vragen ze moeilijk vonden, maar we 
controleerden ook òf  ze de vragen goed begrepen hadden. 
De vragenlijst bleek een goede interne consistentie te hebben. Een goede interne 
consistentie betekent dat verschillende vragen in de BSI die hetzelfde willen me-
ten (bijvoorbeeld of  iemand angstig is) dat ook daadwerkelijk doen. Discriminante 
validiteit, ofwel of  de vragenlijst onderscheid kan maken tussen verschillende begrip-
pen, werd aangetoond voor de subschalen somberheid, angst en fobische angst. Met 
confirmatieve factoranalyse, een statistische techniek waarmee je kunt onderzoeken 
hoe de verschillende vragen van een vragenlijst het beste gegroepeerd kunnen worden, 
lieten we zien dat de onderliggende structuur van de BSI bij mensen met een lager 
IQ het model volgt, dus dezelfde subschalen, zoals eerder voor de BSI beschreven bij 
een groep mensen die niet waren geselecteerd op grond van hun IQ. Conclusie uit dit 
onderzoek was dat de BSI een nuttige vragenlijst is voor het meten van psychische 
klachten bij mensen met zwakbegaafdheid of  een lichte verstandelijke beperking.
Omdat er nog maar weinig onderzoek gedaan is naar het effect van zwakbegaafdheid 
op het soort en de ernst van de psychische klachten, oftewel hoe psychiatrische stoor-
nissen er uit zien, bestudeerden we in hoofdstuk 6 de meetresultaten op de BSI, di-
rect de eerste keer dat hij werd afgenomen, bij zwakbegaafde patiënten met ofwel een 
depressieve stoornis, of  een posttraumatische stressstoornis. We vergeleken de scores 
op de verschillende subschalen van de BSI en de BSI totaalscore van zwakbegaafde 
patiënten met de scores van mensen in de ‘reguliere’ psychiatrische zorg en mensen 
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met een lichte verstandelijke beperking. Om er voor te zorgen dat verschillen in scores 
niet veroorzaakt werden door leeftijd of  geslacht werd hiervoor gecorrigeerd. 
Uit dit onderzoek bleek dat zwakbegaafde depressieve patiënten minder ernstige 
depressieve klachten aangaven dan depressieve patiënten onder behandeling in de regi-
onale centra van Rivierduinen. Ze gaven ook minder klachten aan op de subschalen 
Problemen in de cognitieve functies en Teruggetrokkenheid. 
Er waren geen grote verschillen in BSI scores tussen patiënten met een posttrauma-
tische stressstoornis uit de verschillende groepen. Wel scoorden licht verstandelijk 
beperkte patiënten met een posttraumatische stressstoornis lager op de subschalen 
Depressie en Teruggetrokkenheid dan patiënten uit de regionale centra van Rivierduinen. 
Omdat dit de eerste studie is die op deze manier psychische klachten vergelijkt tussen 
mensen met een hoger of  een lager IQ wilden we vooral deze verschillen laten zien, 
maar we kunnen ze nog niet zo goed verklaren.
De laatste studie, die we beschrijven in hoofdstuk 7, is een eerste verkennende studie 
naar het verband tussen geslacht, leeftijd, IQ en cluster B persoonlijkheidsstoornissen 
en behandeluitkomst bij poliklinische patiënten met stemmings-, angst- en somato-
forme stoornissen. We spreken in de psychiatrie van een persoonlijkheidsstoornis als 
iemand een vaste, starre manier van reageren heeft ontwikkeld op zeer uiteenlopen-
de omstandigheden en daardoor persoonlijk of  sociaal vastloopt. Mensen met een 
Cluster B persoonlijkheidsstoornis zijn impulsief  en vinden het moeilijk om met hun 
emoties om te gaan.
Voor deze verkennende studie gebruikten hiervoor de resultaten zoals die werden 
vastgesteld met de BSI die tenminste twee keer was afgenomen: de eerste keer keer 
voor het begin van de behandeling en de tweede keer als de behandeling al een eind 
gevorderd is of  is beëindigd. Bij 93 patiënten van Kristal keken we op die manier naar 
de invloed van geslacht, leeftijd, IQ en cluster B persoonlijkheidsstoornissen op het 
effect van de behandeling. Waarschijnlijk door het relatief  kleine aantal patiënten was 
het voor de uitkomsten van dit onderzoek niet mogelijk om geheel uit te sluiten dat de 
uitkomsten niet op toeval berusten. Daarom kunnen we slechts voorzichtig zeggen dat 
het er op lijkt dat vrouwen, jong volwassenen en patiënten met een comorbide cluster 
B persoonlijkheidsstoornis, minder goed reageren op behandeling. Het maakte voor 
het effect van de behandeling niet uit of  mensen zwakbegaafd waren of  een lichte 
verstandelijke beperking hadden. Zwakbegaafde patiënten reageerden niet beter of  
slechter op behandeling dan patiënten met een lichte verstandelijke beperking. 
Dit is een kleine, eerste, verkennende studie. Het zou mooi zijn als hij herhaald kan 
worden met grotere groepen patiënten. Dan kunnen ook andere factoren die mogelijk 
van invloed zijn op het effect van behandeling onderzocht worden.
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Algemene discussie 
Er is weinig aandacht voor zwakbegaafdheid in de GGZ en er wordt nauwelijks 
onderzoek naar gedaan. Dat is vreemd. Zwakbegaafdheid komt namelijk veel voor. 
Het gaat om een grote minderheid, zowel in de maatschappij als in de GGZ. In dit 
proefschrift bestuderen we, voor de eerste keer, psychiatrische stoornissen en de 
aard en ernst van psychische klachten bij zwakbegaafde poliklinische patiënten. Het 
is daarbij heel bijzonder dat we de mogelijkheid hadden om zwakbegaafde patiënten 
te vergelijken met zowel patiënten uit de ‘reguliere’ psychiatrie als patiënten met een 
lichte verstandelijke beperking. 
Het herkennen en vergelijken van deze verschillende patiëntengroepen is belangrijk 
vanwege de mogelijke implicaties voor diagnostiek en behandeling.
In dit proefschrift lieten we zien dat sommige psychiatrische stoornissen vaker of  juist 
minder vaak worden vastgesteld bij zwakbegaafde patiënten dan bij patiënten in de ‘re-
guliere’ zorg of  bij patiënten met een lichte verstandelijke beperking. Dit is belangrijke 
informatie omdat het invloed heeft op de manier waarop je de geestelijke gezond-
heidszorg voor deze groep patiënten organiseert. Dat veel zwakbegaafde patiënten een 
posttraumatische stressstoornis hebben bijvoorbeeld, betekent dat er behoefte is aan 
goed opgeleide behandelaren, die weten hoe ze behandelingen voor posttraumatische 
stressstoornissen kunnen toepassen, specifiek toegespitst op mensen met een lager IQ.
Dat zwakbegaafde patiënten vaak een persoonlijkheidsstoornis hebben betekent dat 
ook daar aangepaste behandelingen nodig zijn. In de ‘reguliere’ psychiatrie worden 
over het algemeen erg ‘cognitieve’ therapieën gebruikt, zoals dialectische gedragstherapie 
(DGT) en Mentalisation Based Therapy (MBT) die voor veel patiënten met een lager IQ 
te moeilijk zijn. Psychiatrische patiënten met een lager IQ hebben behoefte aan een 
behandeling met kleine concrete stappen en veel herhaling. Terwijl patiënten met een 
gemiddeld of  hoger IQ zelf  in allerlei situaties kunnen toepassen wat ze in de therapie 
in een enkele situatie hebben geleerd, moet dat zwakbegaafde mensen in veel meer 
situaties geleerd worden: er moet meer aandacht zijn voor generalisatie. Kristal Cen-
trum voor Psychiatrie en Verstandelijke Beperking heeft de expertise voor aangepaste 
behandelingen voor posttraumatische stressstoornissen en voor persoonlijkheidsstoor-
nissen.
Een belangrijke uitkomst van dit proefschrift is de bruikbaarheid van de BSI bij pati-
enten met zwakbegaafdheid of  een lichte verstandelijke beperking. Dit heeft de moge-
lijkheden van ROM absoluut vergroot. Omdat de BSI zowel bij mensen met een hoger 
als met een lager IQ gebruikt kan worden, kan er met behulp van deze vragenlijst 
gekeken worden naar overeenkomsten en verschillen tussen deze patiëntengroepen. 
Je kunt bijvoorbeeld kijken of  er verschillen zijn in de aard en ernst van psychische 
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klachten of  kijken naar de effectiviteit van verschillende behandelingen bij mensen die 
op verschillende intellectuele niveau’s functioneren. 
In dit proefschrift hebben we deze mogelijkheden verkend door BSI symptoompro-
fielen, ofwel scores op de verschillende subschalen en scores van de BSI totaal, van 
zwakbegaafde patiënten te vergelijken met patiënten uit de regionale centra van Rivier-
duinen en patiënten met een lichte verstandelijke beperking. Ook onderzochten we 
met behulp van de BSI mogelijke voorspellers voor het effect van een behandeling. 
Algemene conclusies en aanbevelingen voor verder onderzoek
De resultaten van de studies in dit proefschrift laten zien dat het mogelijk is onder-
zoek te doen naar zwakbegaafdheid in de geestelijke gezondheidszorg. Focus op zwak-
begaafdheid is belangrijk omdat zwakbegaafde patiënten in de GGZ een grote –en tot 
nu toe zeer beperkt herkende- groep vormen.
Volgens het Sociaal Cultureel Plan Bureau heeft ongeveer 2,2 miljoen mensen in Ne-
derland een IQ tussen 70 en 85. In hun rapport “Zorg beter begrepen”, concludeert 
het Sociaal Cultureel Plan Bureau dat de zorgbehoeften van zwakbegaafde mensen 
tussen 1998 en 2011 verzesvoudigd zijn. Maatschappelijke ontwikkelingen zoals 
verminderde beschikbaarheid van eenvoudig werk, hogere eisen in het onderwijs en 
toenemende digitalisering zijn de belangrijkste verklaringen voor deze toename van 
de zorgbehoefte. Ondanks, of  misschien wel vanwege deze toenemende zorgvraag 
heeft de Nederlandse regering besloten terughoudender te worden in het aanbieden 
van gespecialiseerde zorg voor zwakbegaafde mensen. Dit vermindert de ruimte voor 
preventieve zorg en begeleiding waardoor niet alleen het risico op psychosociale en 
gezondheidsproblemen toeneemt maar met name het risico op het ontwikkelen van 
psychiatrische stoornissen
Veel zwakbegaafde patiënten in de GGZ hebben een combinatie van vaak complexe 
psychiatrische stoornissen, een verscheidenheid aan psychosociale problemen en pas-
send bij hun zwakbegaafdheid, cognitieve beperkingen en beperkingen in het sociaal 
emotionele en adaptieve functioneren.
Om deze complexe interactie tussen zwakbegaafdheid, psychiatrische stoornissen en 
psychosociale problemen adequaat aan te pakken is een actieve opsporing van zwakbe-
gaafdheid in de geestelijke gezondheidszorg essentieel. Professionals moeten worden 
getraind in het herkennen van zwakbegaafdheid èn in de extra praktische en commu-
nicatieve vaardigheden die nodig zijn voor adequate diagnostiek en behandeling van 
psychiatrische stoornissen bij zwakbegaafde patiënten. 
Er is behoefte aan onderzoek naar bestaande diagnostische - en behandelmodules op 
bruikbaarheid en effectiviteit bij zwakbegaafde psychiatrische patiënten. Op die ma-
nier organiseren we betaalbare zorg op maat voor een grote groep aan GGZ patiënten 
die veel te lang ongezien is geweest.
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List of abbreviations
ADD   Attention Deficit Disorder
ADHD  Attention deficit hyperactivity disorder 
ANOVA  Analysis of  variance
ANX   Anxiety
BIF  Borderline intellectual functioning
BSI   Brief  Symptom Inventory
CFI   Comparative fit index
CI  Confidence interval
CPID   Centres for psychiatry and intellectual disability
DEP   Depression
DM-ID  Diagnostic Manual-Intellectual Disability
DSM   Diagnostic and Statistical Manual
EDIT   Early detection and intervention team
FACT   Functional assertive community treatment
HR   Hazard ratio
ICD   International Classification of  Disease
ID   Intellectual disability
IQ   Intelligence quotient
I-S   Interpersonal Sensitivity
LVB   Lichte verstandelijke beperking
LVG   Licht verstandelijk gehandicapt
LUMC   Leiden University Medical Centre
MAS   Mood, anxiety and somatoform 
MDD   Major depressive disorder
NFI   Normed Fit Index
NOS   Not otherwise specified
O-C   Obsession-Compulsion
OR   Odds ratio
PAR   Paranoid ideation
PHOB   Phobic anxiety
PD   Personality disorder
PDD   Pervasive developmental disorder
PSY   Psychoticism
PTSD   Posttraumatic stress disorder
RMSEA  Root mean square error of  approximation
ROM   Routine outcome monitoring
SCL    Symptom checklist
SD   Standard deviation
SOM   Somatisation
SPSS   Statistical Package for the Social Sciences
TIQ   Total intelligence quotient
WAIS   Wechsler Adult Intelligence Scale
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Mijn eerste onderzoekservaring dateert uit de tijd dat ik voor mijn keuzeco-schap 
werkte op de afdeling kinder- en jeugdpsychiatrie van Gasthuisberg, het universitaire 
ziekenhuis van de Katholieke Universiteit Leuven. Toen ik als pas afgestudeerde arts 
kwam te werken in het LUMC te Leiden, werkte ik een tijdje mee aan het onderzoek 
van Wendelien Merens. De antwoorden die ik zocht op vragen uit de klinische prak-
tijk wakkerden daarna mijn interesse voor het doen van onderzoek steeds verder aan. 
Tijdens mijn keuzestage bij Kristal Centrum Psychiatrie en Verstandelijke Beperking 
wist ik het zeker: ik wilde onderzoek doen. Klinisch onderzoek. In de praktijk. En dat 
is gelukt. Dankzij hulp van zeer velen.  
Allereerst dank ik mijn patiënten en mijn collega’s. Jullie zijn allen van grote waarde 
geweest voor dit onderzoek. Dankzij jullie ben ik niet alleen een betere onderzoeker, 
maar ook een betere psychiater geworden. Stiekem denk ik dat Kristal dankzij dit 
onderzoek ook een betere instelling is geworden en betere zorg is gaan leveren. Ik zou 
willen dat ik jullie allemaal apart kon noemen. 
Er zijn een aantal mensen die ik in het bijzonder wil bedanken.
Mijn promotor. Geachte professor, beste Frans, samen begrepen we in de loop van de 
jaren steeds beter waar het over moest gaan. Veel heb ik van u geleerd. Dank voor de 
ruimte die u mij gunde om deze weg te vinden. 
Er zijn geen co-promotoren. Wel veel mensen die met mij hebben samengewerkt of  
mij hebben ondersteund: Jonne, Eric, Anke, Tineke, Klaas, Heidi, Eva, Suzanne, Elm-
edina, Martijn, Annemarie, bedankt! Sara, jou noem ik apart. Jij bent een zeer getalen-
teerde psychiater en er zijn weinig mensen met wie ik zo ‘out of  the box’ kan denken 
als met jou. 
Dank ook aan mijn directeuren. Ronald Baas, omdat jij speciaal voor mij een oplei-
dingsplek creëerde bij Kristal en mij aansluitend ruimte gaf  om onderzoek te doen. 
Hanneke van Vliet en Eric van Furth dank ik voor het feit dat ik mijn onderzoek 
steeds mocht voortzetten en Eric in het bijzonder ook voor de focus die nodig was 
om het af  te ronden. 
De leden van de promotiecommissie, professor A.M. van Hemert, professor R.C. van 
der Mast, professor T. van Amelsvoort en professor P.J.C.M. Embregts dank ik zeer 
hartelijk voor het beoordelen van mijn proefschrift.
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Mijn beide paranimfen. Lieve Erica, jouw onvoorwaardelijke steun is van onschatbare 
waarde. Wij samen zijn meer dan de som van onze delen. Met jou als mijn paranimf  
weet ik zeker dat het goed komt. 
Lieve Inez, de meest waanzinnige herinneringen in mijn leven deel ik met jou. Zo fijn 
dat bij jou alles kan. Bijna 10 jaar geleden was ‘onze’ eerste promotie. Eindelijk draaien 
we de rollen om. 
Barbra, Eveline en Leo, dank voor jullie geweldige hulp bij het vormgeven van binnen- 
en buitenkant van dit proefschrift. Er is een fotomodel aan je verloren gegaan, Leo! 
Ook een speciale dank aan alle dames van het secretariaat en de balies van LUMC, 
Rivierduinen en natuurlijk Kristal. Zo fijn dat ik altijd bij jullie terecht kan met al mijn 
vragen, verhalen en gekke klusjes. 
En dan mijn vrienden. Zonder jullie was ik nooit geweest wie ik nu ben. Jullie ma-
ken mijn leven vrolijk. Speciaal noem ik graag mijn vriendinnetjes van de middelbare 
school, Viola, Sabine en Nathalie, omdat jullie al zo lang met mij meereizen in het 
leven. En Aagje. Wij hebben samen meer meegemaakt dan we misschien gewild had-
den, maar daardoor ben en blijf  je me altijd dierbaar. Lieve Bruno, Greet en Steven, 
jullie keuze – onafhankelijk van elkaar gemaakt – heeft op mij een onuitwisbare indruk 
gemaakt. Maar ik zal jullie niet daarom herinneren, maar om alles daarvoor. 
En lieve Leen, jij begrijpt mij als geen ander. Met jou deel ik alles. Ik zou willen dat je 
dichterbij woonde. 
Ella, jij verdient een geheel eigen plek. Dank voor onze bijzondere vriendschap. Wat ik 
van jou leer is niet in woorden uit te drukken. Ik heb zo veel bewondering voor jou. 
Mijn ouders, lieve Ank en Martin, jullie weten hoe oneindig dankbaar ik jullie ben. 
Dankzij jullie komt alles altijd goed. En lieve Jan Jaap en Liesbeth, ik had me geen 
betere broer en zus kunnen wensen. 
Mijn schoonmoeder, lieve Annelies, dankjewel voor je oneindige vertrouwen in mijn 
kunnen. En voor alle keren dat ik op Duifje mocht bijkomen van het harde werken.
En oom Engel en tante Hilly, bedankt. Waar kun je beter zijn, dan binnen de familie. 
Soetie, Enne en Marte, mijn lievelingen. Op jullie ben ik zo trots! En Friso, lief  lief. 
Boni coniuges semper idem volent atque idem nolent. Er zijn geen woorden om aan 
te geven hoeveel jullie voor mij betekenen. 


